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COMPARATIVE VIRULENCE STUDIES OF STAPHYLOCOCCI
CHAPTER I 
INTRODUCTION
Study of the virulence of Staphylococcus aureus is complicated by 
its ability to produce a variety of metabolic substances, most of which 
have been associated at one time or another with its pathogenicity 
(Dubos, 1956; Blair, 1939, 1958; Elek, 1959). Solution of the problem 
of staphylococcal virulence may well depend on future purification and 
characterization of these substances. Furthermore, the lack of a sus­
ceptible, small experimental animal presents an immediate obstacle to 
the investigation of staphylococcal host-parasite relationships. Mice 
are relatively resistant to the ordinary strains of staphylococci en­
countered in human infections. Discovery of strains of unusually high 
virulence for mice could be an important step in the elucidation of 
staphylococcal host-parasite relationships. The present study includes 
an examination of mouse virulence of two such recently isolated strains 
of _S. aureus, which differ from ordinary staphylococci in that their 
cells fail to clump in plasma or fibrinogen, although they are coagulase 
producers. The production of coagulase by the great majority of staph­
ylococci isolated from human infections led to its association with the 
pathogenicity of the organism, and to the extensive investigation of its 
nature and its possible role in the virulence of the organism.
1
2Coagulase
There is, at present, general agreement that coagulase production 
is the most reliable criterion of the potential pathogenicity of staph­
ylococci. Only coagulase-positive staphylococci are isolated regularly 
from lesions. There is almost complete correlation between the ability 
of a staphylococcal strain to clot the citrated plasma of a given animal 
species and its capacity to produce disease in that species. Apparently 
coagulase-negative staphylococci fail to invade, or they are readily 
eliminated from the tissues of man and animals.
Loeb (1903) noted that staphylococci from clinical cases coagulated 
citrated goose plasma and he concluded that "Staphylococcus pyogenes 
aureus has a specific influence in causing coagulation of the blood," 
probably by means of an enzyme preformed in cultures. Earlier workers 
had observed the clotting of horse plasma by a variety of microorganisms, 
including certain infusoria, yeasts, and bacteria (Salvioli, 1894; Elek, 
1959). Salvioli (1894) reported on the loss of blood coagulability when 
sterile filtrates of pyogenic staphylococci were injected intravenously 
into dogs. He also indicated that the same activity was effected by an 
alcohol-precipitable substance which was present in the filtrates of 
staphylococci but not in those of Proteus, vibrios or streptococci.
Much (1908) reported that only the orange pigmented "aureus" strains, 
which he recovered from clinical cases, and not the white "albus" or 
yellow "citreus" strains of staphylococci, nor other bacterial species, 
clotted citrated human and horse plasmas but not sheep plasma. The name 
"staphylocoagulase" was given by Gratia (1920) to the enzyme-like staph­
ylococcal product responsible for the coagulation of plasma. Daranyi
3(1926) was the first to call attention to the usefulness of the plasma 
clotting activity of coagulase as an index of staphylococcal pathogen­
icity. Although it was first thought that living organisms were essen­
tial for the demonstration of coagulase, later studies clearly proved 
that bacteria-free, culture filtrates possessed this activity (Waltson, 
1935; Lominski, 1944; Smith and Hale, 1944; Tager and Hales, 1947;
Duthie, 1952, 1954a,b; Duthie and Haughton, 1958). Coagulation of cit­
rated plasma by microorganisms other than staphylococci has been ex­
plained by their utilization of the citrate in the plasma (Harper and 
Conway, 1948; Evans et , 1952; Mushin and Kerr, 1954; Wood, 1959).
When comparisons were made (Duthie, 1954a) of human plasma and 
those of different animal apecies (sheep, horse, cow, dog, guinea pig, 
mouse, and rabbit), only three human, horse, and rabbit) of the eight 
were clotted by coagulase. The observations of a number of investi­
gators indicated that human and rabbit plasmas are the most susceptible 
to coagulase action. Horse, dog, pig, goat, calf, donkey, and goose 
plasmas are also regularly clotted by coagulase, whereas variable results 
are observed with sheep and ox plasmas (Elek, 1959). Guinea pig plasma 
is susceptible to coagulase action at 20 C but it is resistant at 37 C 
(Smith and Hale, 1944; Kaplan and Spink, 1948; Gerheim and Ferguson, 
1949). Failure of fowl and mouse plasmas to be clotted by coagulase- 
positive staphylococcus has been noted (Smith and Hale, 1944; Gerheim 
and Ferguson, 1949). However, rare clotting of mouse plasma by staphylo­
cocci has been reported by Gorrill (1951).
Calcium is not required for coagulase action since its ionization 
was suppressed with citrates, oxalate, and fluoride (Much, 1908; Miale,
41949b). Heparin, chlorazol-fast pink azo dye, hydroquinone and cobra 
venom also fail to inhibit the plasma clotting activity of coagulase 
(Waltson, 1935; Miale, 1949b; Elek, 1959).
The most widely accepted hypothesis for the mode of action of 
coagulase involves a component of plasma which has been referred to 
variously as coagulase activator, accessory factor, coagulase globulin 
and coagulase-reacting factor or CRF (Smith and Hale, 1944; Tager, 1948a; 
Miale, 1949a; Duthie, 1952; Duthie and Lorenz, 1952). Tager (1956a) 
postulated the following sequence of reactions:
1. coagulase + coagulase-reacting factor (CRF) — y  coagulase-CRF
2. coagulase-CRF + fibrinogen — ^  fibrin.
Another explanation of the coagulase clotting mechanism suggests that 
it is a proteolytic enzyme which activates prothrombin (Eagle, 1937). 
Waltson (1935) proposed that coagulase acts directly on fibrinogen. Re­
cently Murray and Gohdes (1959) expressed the opinion that coagulase is 
a complete enzyme, capable of converting purified and commercial prepara­
tions of fibrinogen to fibrin; that the coagulase-reacting factor merely 
functions as an accelerator of the reaction which could be represented 
as follows:
CRF
coagulase + fibrinogen -- >- fibrin.
Little is known of the nature and kinetics of the reaction between 
coagulase and the coagulase-reacting factor which results in the active 
clotting agent. Smith and Hale (1944) and later Duthie and Lorenz (1952) 
agreed that when the two components, coagulase and its activator, are 
incubated together there is a progressive increase in the clotting ac­
tivity of the mixture, f^ore recently, Haughton and Duthie (1959a)
5demonstrated that the active fibrinogen-clotting agent, , activated
coagulase, resembles human thrombin in certain respects. These authors 
presented evidence that coagulase activator is not permanently altered 
in the reaction, whereas coagulase is destroyed. Therefore they regarded 
the reaction as enzymatic in nature with coagulase serving as the sub­
strate and the activator as the enzyme. According to this idea coagu­
lase is enzymatically degraded by coagulase activator and the active 
clotting agent produced is either the enzyme-substrate complex or a de­
gradation product of coagulase. However, as the authors point out, it 
is possible that coagulase may be destroyed by some factor in plasma 
other than the activator. Plasmin was excluded as being such a factor 
because coagulase destruction occurred in the presence of soybean in­
hibitor, which inhibits plasmin activity. On the other hand, the same 
workers reported that the synthetic amino acids ester, N®<-tol'jene-p- 
sulphonyl-l-argine methyl ester (TAME) which is hydrolyzed by plasmin 
and thrombin (Sherry and Troll, 1954) is also hydrolyzed by activated 
coagulase but not by unactivated coagulase. Furthermore, clotting by 
both thrombin and activated coagulase were inhibited by low concentra­
tions of TAME which suggests that both act on fibrinogen in a similar 
manner.
Coagulase Production 
Although coagulase may regularly be demonstrated in staphylococcal 
cultures of simple digest as well as infusion media, the conditions re­
quired for optimal coagulase production are largely unknown. Staphylo­
cocci will grow in relatively simple, protein-free media, but attempts 
to demonstrate the presence of coagulase in such chemically defined
6media have been unsuccessful (Lominski e^ , 1950; Szeto and Halick,
1958). Fisher (1936a) noted the enhancement of coagulase production by 
the addition of whole blood or plasma to various media. The addition 
of serum or egg yolk to media has also been found to stimulate coagulase 
production (Davies, 1951). There is evidence that the enhancing effect 
of the addition of serum to media is due to albumin (Duthie and Lorenz, 
1952; Duthie, 1954b; Barber and Wildy, 1958). Lominski ^  al. (1953) 
emphasized the possibility that the presence of additional protein in 
the medium may protect against a coagulase-destroying factor. Lack and 
Wailing (1954) suggested that albumin may not actually increase coagu­
lase production, but rather it may protect fibrinogen and fibrin against 
lysis by plasmin. Szeto and Halick (1958) found that cultivation of 
staphylococci in a dialyzate of heart infusion broth resulted in high 
titers of coagulase and made its concentration convenient.
Variation in the coagulase yield of different strains of staphylo­
cocci is common even when they are grown in the same batch of medium or 
in a chemically defined medium, and even within populations of a single 
strain, variants can be found which differ in respect to degree of coagu­
lase production (Smith et £l., 1952). High yields of coagulase were 
associated with R variants and low yields with the S type of growth and 
the changes in coagulase production observed in the case of some staph­
ylococcal strains were related to a changing proportion of R and S var­
iants within the strain. It was noted, however, that the variants were 
not absolutely stable; that there was a greater tendency for the R form 
to give rise to the S form than subsequent variation in the opposite 
direction. For the selection of high coagulase producing variants, which
7incidentally are thought to occur rarely in nature Duthie and Lorenz 
(1952), Boake (1956), Barber and Wildy (1958) used fibrinogen-plasma- 
agar plates. Colonies of the "fast-clotting" variants, as indicated by 
the size of the zone of opacity around the colonies, were often small 
and rough in appearance. However, a direct relationship between the 
size of the opaque zone and production of coagulase in broth could not 
be demonstrated. Several methods have been used by various workers for 
titration of coagulase production in liquid culture media. Basically 
these methods measure either the time necessary for the development of a 
clot or the highest dilution of the coagulase preparation which causes 
clot formation (Tager and Hales, 1947; Tager, 1948b; Duthie, 1954a,b; 
Duthie and Haughton, 1958; Szeto and Halik, 1958).
Purification and Characterization of Coagulase 
Tager (1956a) obtained a 300-fold purified product of coagulase 
from cell-free supernatants of cultures grown in brain-heart infusion 
broth to which a mixture of trace ions had been added. The purifica­
tion was effected by precipitation of the active principle with acetate 
buffer, purification by repeated treatment of the precipitate with eth­
anol in the cold at controlled pH, and separation of impurities from the 
final product by use of low concentrations of ammonium sulfate. The 
purified product was not dialyzable through Visking membranes. Its ni­
trogen content was 14 to 16 per cent; it was inactivated rapidly by 
crystalline trypsin, chemotrypsin and plasmin. In contrast to the rela­
tive thermostability of crude coagulase, it was heat labile. Chromato­
graphy of hydrolyzed coagulase indicated the presence of aspartic acid, 
hydroxyproline or tyrosin, histadine and tryptophan or valine and, thus.
8gave further evidence of its protein nature. Tager reported that his 
purified product was not completely homogeneous on electrophoresis or 
ultracentrifugation.
Duthie and Haughton (1958) concentrated coagulase from filtrates 
of casein-hydrolysate medium cultures by cadmium precipitation. Electro­
phoretic studies showed their product to have an iso-electric point 
around pH 5.3, and ultracentrifugation of the preparation indicated it 
had a minimum molecular weight of approximately 44,000. The purified 
product of Tager as well as that of Duthie and Haughton was highly active 
biologically: intravenous injection into rabbits caused immediate death;
a concentration of 75 uug/ml clotted human plasma in 24 hours and the 
clotting time was inversely proportional to the concentration of the 
coagulase.
The filterability of coagulase is controversial. In the hands of 
certain workers Seitz filtration removed all coagulase activity; whereas 
others did not find this to be so (Waltson, 1935; Fisher, 1936a; Lominski, 
1944). Conflicting results were also obtained when Berkfeld and Chamber- 
land filters were used (Waltson, 1935; Miale, 1949a). Growth of the 
staphylococci in a medium containing 10 to 25 per cent human plasma con­
siderably increases the filtrability of coagulase or of what may be the 
resulting active, plasma clotting principle (Lominski, 1944). Coagulase 
filtrability apparently is affected by the pH of the culture; coagulase 
produced in broths without plasma was filterable through Seitz pads when 
the pH was adjusted to 6.7 or less (Lominski and Milne, 1947). Elek 
(1959) suggested that the filterable product produced in the presence of 
10 to 25 per cent plasma was, in fact, not coagulase, but the coagulase-
9thrombin complex or the activated coagulase of Haughton and Duthie (1959a) 
which is readily filterable and which acts directly on fibrinogen.
Recently, Drummond and Tager (1959a,b), associated a second bio­
logical activity with coagulase: an esterase activity which has a marked
specificity for tributyrin. However, their results suggest that the 
esterase and the plasma clotting activities of coagulase reside in sepa­
rate molecular entities, as indicated by studies of the differential 
effects of heat, trypsin, antiserum fractions, and certain enzyme in­
hibitors. Also, a physical separation of tributyrinase and the clotting 
principle was achieved by cellulose column zone electrophoresis.
The antigenicity of coagulase is well established (Tager and Hales, 
1948b; Rammelkamp et al^. , 1949). The existence of antigenically distinct 
coagulases was first indicated by the studies of Rammelkamp and coworkers 
(1950) who recognized three antigenic types of coagulase produced by 
strains of staphylococci isolated from human sources. Duthie (1952) 
added a fourth antigenic type of coagulase which was produced by a strain 
of bovine origin. Barber and Wildy (1958) correlated antigenic types of 
coagulase and bacteriophage groups. These workers also confirmed previous 
reports of the common occurrence of coagulase neutralizing antibodies in 
human sera and of the observation that an individual may have antibodies 
to one type of coagulase but not to another (Rammelkamp ^  al., 1950; 
Duthie, 1952).
Coagulase-Reacting Factor 
The identity of the coagulase-reacting factor (CRF) and its rela­
tion to the known components of the physiological blood clotting mech­
anism has remained an enigma since it was first proposed by Smith and
10
Hale in 1944. Many observers believe the key to the problem lies in the 
relation of the CRF to prothrombin (Smith and Hale, 1944; Tager and 
Hales, 1948a; Duthie and Lorenz, 1952; Tager, 1956a,b; Haughton and 
Duthie, 1959a,b). Studies of human prothrombin preparations indicate 
CRF activity and suggest that prothrombin and CRF may be identical.
Maximum CRF activity has been associated with globulin fractions 
prepared according to the Mellanby technique or by precipitation with 
ammonium sulfate at concentrations between 33 and 50 per cent saturation. 
By ethanol precipitation following the method of Cohn, the CRF activity 
appears to reside in globulin fractions III-l, III-2, and IV-1. Albumin 
(Fraction V) contains no CRF activity nor does purified fibrinogen (Frac­
tion I). The CRF activity of crude albumin and fibrinogen preparations 
are believed to be due to impurities since these two plasma fractions 
after further purification or crystallization are completely devoid of 
CRF activity (Tager, 1948a; Miale, 1949a; Tager, 1956a).
The physico-chemical behavior of CRF supports the view that it is 
protein in nature. Lipoid extracted plasma was found to retain its orig­
inal CRF activity (Tager, 1948a). Smith and Hale (1944) reported the 
factor to be heat labile. However, Tager and Hales (1948a) found that 
slight CRF activity persisted after heating it to 70 C for 30 minutes; 
and seemingly boiling is required to inactivate it completely (Tager and 
Hales, 1948a; Kaplan and Spink, 1948; Miale, 1949a). Coagulase reacting 
factor is destroyed by pepsin as well as by dilute sodium nitrite (Kaplan 
and Spink, 1948).
Coagulase reacting factor is present in high titers in human and 
rabbit plasma. Rabbit lung and kidney extracts have only 1/10 the CRF
11
potency of the plasma, and the CRT content of other tissues appears to 
be about 1 per cent that of plasma. Extracts of rabbit brain and of 
human platelets show little CRF activity. Only slight variation has 
been observed in the amount of CRF in different samples of human plasma 
(Tager and Hales, 1948c).
Clumping Factor
Much (1908) observed that the addition of a suspension of coagulase- 
positive staphylococci to a drop of citrated human plasma results in an 
immediate clumping of the organisms. He also noted clumping of coagulase- 
positive staphylococci in fibrinogen solution although this solution was 
not coagulated by the staphylococci. Birch-Hirschfeld (1934) noticed 
that when coagulase-positive staphylococci were emulsified in a drop of 
plasma on a slide, rapid clumping of the organisms occurred; that clump­
ing of staphylococci in plasma agreed closely with their plasma clotting 
property. The plasma of man, horse, calf, and guinea pig were active 
for staphylococcal clumping regardless of whether oxalate, fluoride, cit­
rate or heparin was used as the anticoagulant. Birch-Hirschfeld demon­
strated that crude fibrinogen was responsible for the clumping phenomena, 
and she thought that clumping in plasma and coagulation of plasma by 
staphylococci may not be due to the same mechanism. She concluded that 
in the slide test an agglutination of staphylococci was caused by pro­
thrombin and that in the tube test clotting of fibrinogen was effected.
The significance of the clumping of staphylococci in plasma as an 
index of coagulase production and, therefore, of potential pathogenicity 
was soon recognized (Christie, 1940). Cadness-Graves et al. (1943) made 
a large scale comparison of the tube coagulase test and the slide
12
agglutination test and found a good correlation between them. Of 442 
strains recovered from human clinical specimens, all but two gave a 
positive reaction in both tests. It was commonly assumed that both 
tests depended on the activity of a single substance, coagulase (Berger, 
1943). Linsell and Gorrill (1951) threw some doubt on this assumption 
when they found that plasma treated by heat or thiomersalate (merthio- 
late) continued to give a positive slide agglutination test although it 
failed to clot with the same staphylococci.
Duthie (1954a) presented further evidence that the tests were ex­
pressions of different factors and that the "two forms of staphylococcal 
coagulase" were antigenically distinct. Diluted (1:10) human or rabbit 
plasma, heated at 56 C for four minutes, no longer clotted with coagu­
lase or with thrombin, whereas it clumped the cocci, though more slowly 
and less strongly than did unheated plasma. Plasma adjusted to pH 2 and 
then neutralized behaved in the same way as heated plasma. Duthie des­
ignated the factor responsible for clumping of the organisms in plasma 
as "bound coagulase" or, preferably, "clumping factor" in contrast to 
the "free coagulase" which causes the clotting of citrated plasma. He 
concluded that the clumping factor (a) is bound to the cell wall and is 
released only on cell disintegration or autolysis; (b) acts directly on 
the fibrinogen of certain animals to cause it to precipitate and thus 
clump the cells. Free coagulase, he stated, is liberated into the medium 
during growth; it acts on prothrombin, or some closely related substance, 
and converts it to a thrombin-like product which will clot any fibrin­
ogen. In his comparative study of the plasma of different animal species 
(man, sheep, guinea pig, cow, horse, mouse and rabbit) as a source of
13
activator (CRF) for free coagulase and of fibrinogen which was sensitive 
to the clumping factor, only 3 of the 8 plasmas (human, horse and rabbit) 
were good sources of CRF and were clotted readily by free coagulase, 
whereas all but guinea pig and sheep fibrinogen reacted with the clump­
ing factor.
The agglutination of hemolytic streptococci in sera and plasma 
from patients suffering from acute bacterial infections (scarlatina, 
erysipelas, typhoid fever, and pneumococcal pneumonia) has been reported 
(Weaver, 1904; Tillett and Abernethy, 1932; Tillett and Garner, 1934).
The reaction appeared to be caused by a protein which resembled fibrin­
ogen rather than by specific antibodies. When such strains of strepto­
cocci were incubated at 37 C in high dilutions of plasma or fibrinogen 
and then allowed to settle in the cold, they were agglutinated (Tillett 
and Garner, 1934). Duthie (1954a) suggested that streptococci produce 
a substance similar to the clumping factor of staphylococci, and that 
the serum substance involved is a partially denatured fibrinogen similar 
to that obtained by acid or heat treatment of plasma. Duthie (1955) in­
vestigated the action of fibrinogen on certain pathogenic cocci (staph­
ylococci, streptococci and pneumococci), and reported that streptococci 
of group A, C, and G, but not of other groups, adsorb fibrinogen as do 
staphylococci but that the streptococci do not proceed to the second or 
clumping stage as do the staphylococci.
Strong evidence that coagulase and clumping factor are, indeed, 
separate entities is supplied by recognition of rare strains of staph­
ylococci which possess either coagulase or clumping factor activity, 
but not both of these properties (Cadness-Graves et al., 1943; Needham
14
et al., 1945; Williams and Harper, 1946; Duthie, 1954a; Klemperer and 
Haughton, 1957; Jenkins and Metzger, 1959). However, comparative studies 
showed that, in general, coagulase-positive staphylococci also clumped in 
plasma, and thus supported the earlier recommendation of the slide test 
for the presumptive recognition of potentially pathogenic staphylococci. 
Rare strains which lack either coagulase or the clumping factor have been 
isolated from nasal swabs and body surfaces, and they have been considered 
to be of doubtful pathogenicity. Duthie (1954a, 1955) claimed that 
strains of coagulase-positive staphylococci which failed to give a posi­
tive clumping reaction usually clumped in plasma or fibrinogen, though 
never in high titer, after several subcultures. He assumed that either 
the plasma clotting tube test or the slide clumping test may serve as a 
satisfactory guide to the pathogenicity of staphylococci which are re­
covered from lesions.
Partial purification of the clumping factor by precipitation with 
cadium followed by dialysis in acid was achieved by Duthie (1954a).
Study of this preparation revealed that clumping factor resists boiling 
but is destroyed by autoclaving and proteolytic digestion. Like free 
coagulase, it is more stable in the acid than in the alkaline range. In 
the same report, Duthie noted that strains of staphylococci may differ 
in degree of clumping ability as measured by the dilution of fibrinogen 
or plasma in which the clumping reaction occurred. Steward and Kelly 
(1959) observed variation of clumping factor activity with reduction or 
loss of this activity, at different rates in individual strains, after 
storage of cultures and cell suspensions.
Antibody to the clumping factor has been demonstrated in commercial
15
antitoxin, and also in antiserum produced by immunization of rabbits with 
clumping factor preparations of autolyzed cultures that have been par­
tially purified and adsorbed on aluminum phosphate. Antisera which was 
produced by the intravenous or intracardiac injection of heat-killed 
staphylococci into rabbits or guinea pigs contained antibodies against 
the clumping factor. Clumping factor antibody apparently inhibits the 
absorption of the fibrinogen to the surface of the cocci and thus their 
clumping in plasma or fibrinogen, but does not inhibit free coagulase 
activity. Conversely, free coagulase antibody failed to neutralize 
clumping factor activity. Although antibodies to free coagulase seem 
to be specific for a given antigenic type of coagulase, there is no evi­
dence for multiplicity of antigenic types of clumping factor (Duthie, 
1954a, 1955). Though the presence of specific clumping factor antibody 
in normal human sera has not been fully investigated (Duthie, 1954a), 
the use of fibrinogen solution instead of plasma for the demonstration 
of clumping factor by the slide test has been advocated (Berger, 1943; 
Duthie, 1954a; Spencer, 1954) to avoid false positive reactions due to 
staphylococcal agglutinins which may be present in plasma (Hodgson,
1943; Jensen, 1958).
Methods for Detection of Coagulase and Clumping Factor
The plasma clotting tube test is used routinely and the slide ag­
glutination test less commonly for the detection of potentially patho­
genic staphylococci. The merits of both tests and the conditions nec­
essary for reliable results in each have been discussed in detail by 
Elek (1959).
For the demonstration and estimation of the degree of clumping
16
factor activity, Duthie (1954a) substituted a tube method for the so- 
called slide agglutination test.
The plasma agar plate method, in which a high concentration (10 to 
20 per cent) of plasma is incorporated into the agar culture medium, has 
been used with some success for the demonstration of coagulase activity 
(Penfold, 1944; Reid and Jackson, 1945; Williams and Harper, 1946; Clapper 
and Wood, 1954; Lack and Wailing, 1954). In this method, the action of 
coagulase results in a zone of precipitation of fibrin around the staph­
ylococcal colony. Some workers have similarly used fibrinogen agar plates 
which contained small amounts of plasma or serum (Duthie and Lorenz, 1952; 
Boake, 1956; Klemperer and Haughton, 1957). False negative results were 
encountered in the case of highly fibrinolytic strains of coagulase- 
positive staphylococci which digested the precipitated fibrin and thus 
cleared the zone around the colonies (Duthie and Lorenz, 1952; Lack and 
Wailing, 1954). The incorporation of traces of soybean trypsin inhibitor 
into the agar medium was shown to obviate this difficulty in the plate 
method (Lack and Wailing, 1954; Lack, 1957).
Griffith and Ostander (1959) described a simple and inexpensive 
capillary tube method for the determination of the coagulase reaction. 
After 18 hour incubation, the results of the capillary tube test were in 
full agreement with the standard tube test.
Finkelstein and Sulkin (1958) reported on the colonial character­
istics of coagulase-positive and coagulase-negative staphylococci in 
serum-soft agar. All strains produced elongated, feathery colonies in 
a basal medium containing 0.15 per cent agar. On addition of 1 per cent 
normal or immune plasma or serum, the coagulase-positive staphylococci
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formed compact, round colonies, whereas the colonies of coagulase-negative 
strains were elongated and essentially like those grown in the basal soft 
agar medium. The authors explained this observation on the basis of 
antigen-antibody reaction.
Virulence of Staphylococci
Role of Coagulase 
Despite general acceptance of a positive coagulase test as the 
best indication of a potentially pathogenic staphylococcus, little is 
known about the exact role and significance of coagulase as a virulence 
factor (Rammelkamp and Lebovitz, 1956). It is generally held that coagu­
lase, in some way, facilitates the vivo establishment of staphylococci 
either by rendering them more resistant to phagocytosis (Hale and Smith, 
1945; Smith et al., 1947; Rogers and Tompsett, 1952; Selbie and Simon, 
1952; Lack and Wailing, 1954; Tompsett, 1954, 1956; Jackson et al., 1955) 
or by protecting them against the bactericidal activity of serum (Spink 
and Vivino, 1942; Ekstedt and Nungester, 1955; Ekstedt, 1956).
In vitro effect of coagulase on the antistaphylococcal action of 
serum. Coagulase-positive staphylococci grow luxuriantly in normal human 
serum which inhibits growth of coagulase-negative staphylococci. Pillemer 
et al. (1954) noted the resistance of coagulase-positive staphylococci to 
the properdin system. It was postulated that free coagulase, or a sub­
stance associated with it, may be a factor destroying che bactericidal 
properties of serum. The antistaphylococcal serum factor was shown to 
be heat labile, and not specific in the immunological sense (Ekstedt, 
1956).
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Recently, Wlodarczak and Jeljaszewics (1959) demonstrated that 
coagulase-negative staphylococci are not always destroyed by serum. They 
found that, in most instances, the number of bacteria which survived 24 
hours incubation in serum was about the same as before incubation. The 
same workers reported that fresh human serum had full bactericidal action, 
while those stored in frozen state were bacteriostatic, and those stored 
at 4 C for seven days were neither bacteriostatic or bactericidal. These 
workers confirmed previous observations (Ekstedt, 1956; Ekstedt and Yotis, 
1959) that the addition, to serum, of a cell-free Seitz culture filtrate 
containing a high concentration of coagulase will establish the growth 
of coagulase-negative staphylococci in the serum, but they also found 
that preparation of purified coagulase did not promote the growth of 
coagulase-negative staphylococci in human serum. It has been shown that 
the addition of partially purified coagulase to normal serum stimulated 
the respiration of both coagulase-positive and coagulase-negative staph­
ylococci; however, the resulting increase in the respiratory rate of the 
coagulase-negative staphylococci was twice as great as that of the coagu­
lase-positive organisms (Ekstedt and Yotis, 1959; Yotis and Ekstedt,
1959). Evidence does not justify the idea that coagulase per se is the 
factor which impairs the antistaphylococcal activity of human serum.
The identity of this factor has yet to be determined (Wlodarczak and 
Jeljaszewics, 1959).
In vitro effect of coagulase on phagocytosis. Depression of phago­
cytosis by staphylococcal products was reported by Pike (1934) who sus­
pected the presence of a leucocidin in the culture filtrates. The abil­
ity of coagulase to inhibit phagocytosis was advanced by Hale and Smith
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(1945) as an explanation for the pathogenicity of coagulase-positive 
staphylococci. Previously, the same workers (Smith and Hale, 1944) had 
shown that the correlation between coagulase production and pathogenicity 
held only when the plasma of the animal concerned was clotted by coagu­
lase. Thus, they postulated, the inhibition of phagocytic activity may 
be an important, if not the factor which determines the host range of 
staphylococci with the susceptible animal species comprising those whose 
plasma is clotted by coagulase. Their studies of phagocytosis of staph­
ylococci in defibrinated and citrated human plasma revealed less effec­
tive phagocytosis of coagulase-positive than coagulase-negative strains. 
Their observations of stained smears suggested that coagulase-positive 
staphylococci resist phagocytosis due to the presence of a protective 
fibrin coat around these organisms. Furthermore, phagocytosis of coagu­
lase-positive staphylococci was inhibited when the organisms were first 
treated with plasma, whereas serum was without this effect.
Rogers and Tompsett (1952) using a suspension of human polymorpho­
nuclear leukocytes in plasma, observed an initial rapid fall in the number 
of culturable coagulase-positive and coagulase-negative staphylococci, 
but, thereafter, they noted a significant difference in the rate of the 
two types of organisms. Whereas the number of coagulase-negative staph­
ylococci continued steadily to decline, the number of viable coagulase- 
positive organisms, after an initial 4 to 8 hour decline, rapidly in­
creased and multiplication soon assumed a logarithmic form. The latter 
course of events was associated with a steady fall in the total leukocyte 
count. Prior removal of fibrin from the system did not influence the 
sequence for either type of organism. It was evident that coagulase-
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positive staphylococci survived phagocytosis by human polymorphonuclear 
leukocytes, whereas coagulase-negative staphylococci did not. The same 
results were obtained when Tompsett (1954) studied the fate of staphylo­
cocci within mononuclear phagocytes obtained from rabbits. Electron 
microscopic studies of the interaction between staphylococci and human 
neutrophils further confirmed the ability of coagulase-positive staphylo­
cocci to survive within the phagocytes (Goodman and Moore, 1956; Goodman 
et £l., 1956). Thus, as in the case of Brucella (Shaffer et al., 1953), 
tubercle bacilli (Mackaness, 1952) and Neisseria (Thayer ^  al.> 1957), 
coagulase-positive staphylococci may find, within the host cell, a shelter 
from unfavorable body climates (Rogers, 1959). Braude and Feltes (1953) 
indicated however that the initial fall in the number of culturable or­
ganisms may be inherent in the experimental method. The authors suggested 
that the intracellular and extracellular clumping of the cocci would lower 
the count of culturable organisms.
Recently, Kapral and Shayegani (1959) used a tissue culture proce­
dure which permitted quantitative evaluation of the intracellular survival 
of staphylococci. They reported that normal human and rabbit leukocytes 
did not permit intracellular multiplication, but only survival of virulent 
staphylococci; that, within human and rabbit leukocytes, coagulase- 
negative staphylococci were destroyed. On the other hand, rat monocytes 
destroyed both coagulase-positive and coagulase-negative staphylococci.
The experiments of Kapral and Shayegani were performed in the presence 
of streptomycin in order to control extracellular multiplication of the 
organisms as well as in its absence.
Cohn and Morse (1959) investigated the fate of staphylococci in
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suspensions of rabbit polymorphonuclear leukocytes by a method which 
simultaneously evaluated both phagocytosis, _i.^ . , ingestion, and intra­
cellular inactivation of the bacteria. Coagulase-positive strains of 
aureus were not efficiently ingested in the presence of normal rabbit 
serum, whereas coagulase-negative staphylococci were rapidly engulfed 
and inactivated. Immune serum which was prepared against a coagulase- 
positive strain and which contained thermostable opsonins for this strain, 
enhanced the ingestion of the homologous organism as well as of three 
heterologous strains of aureus. Once the staphylococci were ingested 
by the phagocyte, prompt intracellular killing of the organisms occurred.
A comparison between polymorphonuclear leukocytes obtained from normal 
and immune animals revealed no difference in their ability either to in­
gest or to kill coagulase-positive staphylococci. The fact that staph­
ylococcal antibodies are common in human sera may explain previous reports 
that virulent and avirulent strains of staphylococci are ingested with 
equal avidity by phagocytes.
In vivo action of coagulase. Whether or not the ^  vitro plasma 
clotting activity of coagulase also occurs ^  vivo is controversial.
Fisher (1936a) found that intravenous injection of large doses of culture 
filtrates of coagulase-positive staphylococci into rabbits failed to pro­
duce evidence, either during the life of the animal or at postmortem, of 
intravascular clotting. He concluded that coagulase action is primarily 
a test tube phenomenon. However, mc>i.e recently, the intravenous injec­
tion of small amounts of purified coagulase, free of alpha hemolysin, 
has been found to be lethal for rabbits (Tager, 1956a; Duthie and 
Haughton, 1958). Smith and Johnstone (1956, 1958) claimed that coagulase
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can exercise its clotting activity ^  vivo. The intravenous injection 
into rabbits of a potent preparation of purified coagulase produced fi­
brinogen depletion and intravascular clotting with multiple fibrin de­
posits occluding capillaries and small vessels especially in the lungs 
and to some extent in liver and kidneys. On the other hand, mice sur­
vived the intravenous injection of the same coagulase preparations and 
no changes were observed in sacrificed mice.
Evidence for coagulase as a virulence factor in experimental staph­
ylococcal infections. Studies of staphylococcal virulence in experimental 
animals have recently been reviewed by Elek (1959). A variety of animal 
species, including the rabbit, mouse, guinea pig, rat, hamster, adult 
birds as well as the developing chick embryo have been used. The viru­
lence of staphylococci for various animal species has been related to 
the susceptibility of the animal plasma to clotting by coagulase (Hale 
and Smith, 1945). Animals, such as guinea pigs and mice whose plasma is 
generally not clotted by coagulase are relatively refractory to staphylo­
coccal infection. However, infection has been produced experimentally 
in an occasional guinea pig whose plasma was clotted by certain strains 
of staphylococci (Smith et al., 1947). Although enormous intravenous 
doses of coagulase-positive staphylococci (more than 200 million viable 
organisms) were required to kill mice, virulence of these organisms was 
enhanced if they were suspended in a coagulable menstruum before intra­
venous or intraperitonea1 injection into mice. Likewise, the production 
of abscesses in the guinea pig was made possible by subcutaneous injection 
of staphylococci at a site previously prepared by introduction of a coag­
ulable plasma from another animal species. These results suggested that
23
coagulase plays a major role in the initiation and development of the 
staphylococcal lesion, probably by laying down a fibrin barrier around 
the organisms, after which other factors, such as toxins, come into 
action.
Boake (1956) reported on the protective effects of anti-coagulase 
in experimental staphylococcal infections. Rabbits actively immunized 
with coagulase were more resistant to intravenous challenge with coagu­
lase-positive, but not with coagulase-negative staphylococci. Boake 
injected mice intraperitoneally with coagulase-positive staphylococci 
suspended in a clotting system (fibrinogen and CRF). Serum from rabbits 
immunized with coagulase preparation diminished the virulence of these 
organisms when it was allowed to come in contact with them for 30 minutes 
before the addition of the clotting system. Similar results were ob­
tained, under the same conditions, by using human serum which contained 
coagulase inhibiting antibodies. This diminution of virulence was not 
effected by alpha antitoxin or by staphylococcal agglutinating serum. 
Boake concluded that the decrease in virulence observed in mice was due 
to neutralization of coagulase and that the active immunity observed in 
rabbits was probably associated with the ^  vivo inhibition of coagulase 
activity.
More direct evidence of the enhancing effect of coagulase on staph­
ylococcal virulence was reported by Ekstedt and Yotis (1959). When 
coagulase-negative staphylococci were treated with purified coagulase 
and a standard dose (1 to 5 million organisms) was injected intracere- 
brally into mice, as high as 72 per cent mortality resulted instead of 
the usual 1 per cent mortality produced by the untreated staphylococcal
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suspensions.
The influence of route of injection on mouse susceptibility to 
staphylococcal infections is not clear. A good correlation was shown 
between the severity of the disease in the patient and the pathogenic 
effect of staphylococci on mice when injected intravenously (Smith et al., 
1947) or intraperitoneally (Fisher and Thompson, 1956). The studies of 
Christie £t £l. (1946) and Lack and Wailing (1954) suggested the relative 
resistance of mice to staphylococci injected via the intraperitonea1 
route. Fisher and Thompson (1956) indicated that if very large inocula 
are used for the intraperitoneal injection of mice, death of the animals 
may result when potentially virulent staphylococci are used. Gorrill 
(1951) remarked that mice are extremely resistant to staphylococci in­
jected intraperitoneally or intranasally, but are susceptible to the 
intravenous injection of coagulase-positive staphylococci. In contrast, 
Dutton (1955) observed that staphylococci were less lethal for mice by 
the intravenous route than by the intraperitoneal or subcutaneous routes.
Mice have been found susceptible to the intravenous injection of 
coagulase-positive staphylococci. The intravenous injection of 0.1 ml 
overnight broth culture which contained 400 million cells of coagulase- 
positive staphylococci proved lethal for mice, whereas similar doses of 
coagulase-negative strains were ineffective (Gorrill, 1951). Eleven out 
of the 12 coagulase-positive strains tested by Gorrill clotted mouse 
plasma regularly, while the other strain clotted 2 out of 8 different 
mouse plasmas (Gorrill, 1951).
Smith and Dubos (1956a) injected mice intravenously with graded 
doses, 0.03 to 0.6 ml, of 18 hour broth cultures of staphylococcal strains
25
that failed to clot mouse plasma. Whatever the dose injected, coagulase- 
negative and weakly coagulase-positive strains caused no death in mice.
In contrast, all coagulase-positive staphylococci caused a certain per­
centage of deaths, depending on the strength of coagulase production, 
when the injected dose was 0.1 ml of cultures. Strong coagulase pro­
ducers were lethal in various percentages when 0.03 to 0.1 ml doses were 
injected. Although virulence appeared to be correlated with the pro­
duction of coagulase, it did not seem however to depend upon the activity 
of this substance to interfere with the bactericidal mechanism of the 
mouse organs during the early phase of infection. Virulence was mani­
fested by kidney abscess formation from few cocci that escaped initial 
destruction.
Subsequently, Gray ^  aj.. (1957) made a systemic investigation 
similar to that of Smith and Dubos (1956a) to further characterize ex­
perimental staphylococcal infection of mice by histopathological, hemato­
logical, and quantitative bacteriological studies. When introduced by 
the intravenous route, an inoculum of 0.2 ml of coagulase-positive staph­
ylococcal broth culture containing 100 million cells was effective and a 
15 per cent mortality in 120 infected animals was recorded. The majority 
of these deaths occurred between the 7th and 14th days after infection.
In general, the results of Gray and his group were in agreement with 
those of Smith (1956) and Smith and Dubos (1956a). There was an Initial 
high bacterial count in the various organs followed by a steady decline 
after which there was a slight rise at the 9th to 14th day, except for 
the kidneys in which there was an actual increase in the number of or­
ganisms recovered. This increase reached its maximum between the 5th
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and the 7th day after which there was a levelling off. Multiple abscess 
formation in the kidneys was most extensive 10 days post infection. The 
histopathological picture revealed the development of suppurative nephri­
tis, pyelonephritis and urocystitis.
The development of abscesses in the mouse kidney, following intra­
venous inoculation of coagulase-positive staphylococci was investigated 
further by Gorrill (1958). The studies of Gorrill included a comparison 
of the death rates and the rates of renal infection; the latter was 
found to be a more sensitive indicator of infection. Graded doses of
0.5 ml, which contained 2.7 x 10^  to 2.1 x 10^  of saline suspended cocci, 
were injected intravenously. A roughly linear relationship was obtained 
between the number of kidneys infected or the number of mice killed and 
the logarithm of the dose injected. This led the author to the use of 
K. I.D. 50 dose, which is the number of cocci which on intravenous injec­
tion into mice will infect half the kidneys. Thus, it was possible for 
him to relate the number of cells deposited in the kidney to the fre­
quency of renal infection. Following the intravenous injection, the or­
ganisms were distributed throughout the body with the vast majority in 
the reticuloendothelial tissues. It was thought that few cocci are de­
posited in the kidneys, possibly purely mechanically trapped in vessels 
or by being trapped in vessels which were closed by physiological changes. 
The number of organisms lodged in the kidneys depended on the size of the 
dose; with larger doses, some would divide and establish themselves before 
the cellular defenses of the body are alerted. Gorrill also suggested 
that abscess formation in the kidneys leads to the death due to disturbed 
renal function and toxemia. Infection may however be overcome gradually
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and the damage is repaired with fibrous tissue. These findings are 
essentially in agreement with those of other investigators (Smith et al., 
1947; Smith and Dubos, 1956a; Gray ^  al., 1957; Rogers, 1959).
Other changes observed in mice infected with staphylococci via the 
intravenous route included marked neutrophilia (Gray et £l., 1957) as 
well as dehydration and loss of weight (Smith and Dubos, 1956a; Gray 
£t a^., 1957; Sellers :and LeMaistree, 1960). Lesions were occasionally 
observed in organs other than the kidney, especially in the lungs and 
spleen (Smith, 1956; Smith and Dubos, 1956a; Gray et al., 1957; Sellers 
and LeMaistree, 1960). In some mice there were also myocardial abscesses 
and areas of acute interstitial pneumonia (Gray et , 1957).
The intraperitoneal route of injection for the study of virulence 
of staphylococci for mice has been used by several investigators. On 
the average, high numbers of staphylococci were required to produce lethal 
effects in mice (Christie ^  aj.. , 1946; Howard, 1954; Lack and Wailing, 
1954; Fisher and Thompson, 1956; Hunt and Moses, 1958; Ifyers, 1959). The 
suspension of staphylococci in mucin was shown to enhance their virulence 
for mice by the intraperitoneal route (Schneierson and Amsterdam, 1956; 
Amsterdam and Schneierson, 1957; Hunt and Moses, 1958; Fisher, 1959).
Hunt and Moses (1958) reported on the production of acute infection 
of mice by the intraperitoneal injection of a variant of the Smith staph­
ylococcus strain. The differentiation and isolation of this variant was 
accomplished by the application of the soft agar technique of Finkelstein 
and Sulkin (1958). While the parent strain formed compact colonies in 
plasma-soft agar, the variant showed elongated, diffuse colonial growth. 
Both strains, however, produced coagulase as determined by the tube test.
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The of the variant strain was approximately 4 x 10^  when a broth
culture was injected, but when the organisms were suspended in 5 per cent 
hog gastric mucin, the LD5Q was approximately 580 cells per mouse. In 
contrast, studies of ordinary strains of coagulase-positive staphylococci, 
including the parent Smith strain, resulted in an ID^g of 1 x 10^ viable 
cells in mucin, although these organisms did not consistently cause death 
when 1 X 10^  viable cells were injected without mucin. The response of 
mice to infection included prompt leukocytosis and phagocytosis of the 
staphylococci regardless of whether the compact or the diffuse colony 
type was injected. Organisms of the compact type were viable but multi­
plied only slightly within the phagocytes. In contrast, the diffuse type 
showed a marked proliferation within the leukocytes 8 to 12 hours after 
the injection and the length of the intracellular proliferation period 
depended on the size of the challenging dose. At the end of the 8 to 
12 hour period, there was abrupt appearance of overwhelming number of 
extracellular organisms and the mice died within the next 20 to 40 min­
utes. Intracellular growth and high concentration of delta hemolysin 
within the leukocytes were postulated to account for the sudden extra­
cellular appearance of the diffuse type staphylococci. Fisher and 
Thompson (1956) indicated earlier the rapid lethal effect for mice of 
high challenging doses of staphylococci, and a toxic, heat-labile sub­
stance, which was inseparable from actively growing bacteria, was in­
criminated. The histopathological studies of Fisher and Thompson re­
vealed production of pleural effusion with positive fluid cultures and 
visible pulmonary congestion or hemorrhage in the mice infected with 
virulent strains.
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Significance of the Clumping Factor in 
the Virulence of Staphylococci 
Johanovsky (1957b) has been the only one to investigate the signi­
ficance of the clumping factor in the virulence of staphylococci. He 
injected mice intraperitoneally with strains of coagulase-positive staph­
ylococci possessing the clumping factor and others lacking it, and found 
that the amount of the lethal dose depended on the formation of alpha 
toxin and the presence of the clumping factor. The author suggested that 
the clumping factor rather than coagulase may contribute to the resistance 
of pathogenic staphylococci to phagocytosis and to their survival in 
leukocytes.
Physiological Properties and Metabolic Products Associated 
with Coagulase and/or Pathogenicity of Staphylococci 
It is well known that there is a high degree of correlation between 
the ability of staphylococci to cause disease in man and experimental 
animals and certain ^  vitro properties of the organism other than coagu­
lase activity. Staphylococci which produce coagulase regularly possess 
a number of these properties which have been associated with staphylo­
coccal virulence (Blair, 1958; Elek, 1959; Sonnenwirth, 1959).
Toxins
Since early in the century, it has been known that when certain 
staphylococci are grown under suitable conditions, they give rise to a 
toxic filtrate which has a variety of effects. Such a toxic filtrate 
causes acute and fatal toxemia when injected intravenously into rabbits 
or mice. When injected intradermally into the skin of rabbits or guinea
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pigs, it causes necrosis. It is hemolytic, especially for rabbit and 
sbeep red blood cells, and it bas a destructive effect on leukocytes 
(Parker, 1924; Wilson and Miles, 1955; Blair, 1958; Elek, 1959). Although 
opinions differ, it appears that most investigators still accept the 
monistic view proposed by Burnet (1929), and which considers the various 
effects of the toxic filtrate as different manifestations of the activity 
of a single substance (Blair, 1958). This view is strengthened by several 
observations such as that of Pillemer and Robbins (1949) who found that 
the dermonecrotic, lethal, and hemolytic activities are associated with 
a purified toxin. Since the activity of alpha hemolysin can be most con­
veniently measured vitro, it gradually became the basis for detecting 
and measuring staphylococcal toxin and antitoxin (Elek, 1959).
Kleiger and Blair (1940) pointed out the close similarity between 
the response of experimental animals to intravenous injection of toxic 
filtrates and the clinical symptoms of acute staphylococcal toxemia in 
children from whom highly toxigenic staphylococci were isolated. The 
same workers (Kleiger and Blair, 1943) suggested that the toxin plays a 
considerable role in the pathogenesis of acute human staphylococcal toxe­
mia since adequate therapeutic doses of antitoxin often improved the 
clinical picture. On the other hand, the production of intense necrosis 
following the intradermal injection of potent toxic filtrates in rabbits 
and the common observation that many, if not all, strains from cutaneous 
lesions are toxigenic (Marks, 1952), led to the assumption that the exo­
toxin may be important in the initiation of infection in intact skin 
(Blair, 1958). Elek (1956), however, indicated that multiplication of 
cocci is necessary to the establishment of purulent lesions in the skin
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of human volunteers, whereas injection of sterile toxic filtrates failed 
to produce such lesions.
Some strains of coagulase-positive staphylococci produce under 
favorable conditions an enterotoxin which is distinct from other staph­
ylococcal products and is capable of giving rise to acute food poisoning 
in man (Dack et aj.., 1930; Dack, 1937, 1956). Studies on enterotoxin 
properties are confusing and incomplete chiefly because of lack of suit­
able assay method (Wilson and Miles, 1955; Blair, 1958).
Highly purified enterotoxin has been characterized by Bergdoll 
(1956) as a water soluble, antigenic protein with a high percentage of 
lysine. It has a molecular weight of 15,000 to 25,000 and an isolecteric 
point near pH 8.5. However, it is resistant to trypsin. Earlier, Davison 
and Dack (1939) reported that boiling for 30 minutes causes little reduc­
tion in the potency of the enterotoxin, but 60 minutes boiling leads to 
an appreciable loss, and autoclaving results in almost complete destruc­
tion.
The mode of action of enterotoxin is not known (Dack, 1956; Elek, 
1959). It has been suggested that the site of emetic action may be lo­
calized in the peripheral sensory structures, the probable principal path­
ways being the vagi (Bayliss, 1940), or the enterotoxin may act directly 
on the gastric mucosa (Palmer, 1951). Symptomatology of staphylococcal 
food poisoning strongly suggests involvement of the nervous system (Holt- 
man and Peterson, 1952). These workers used a nerve-muscle preparation 
of the frog to prove that a direct neurotoxic action takes place. When 
the sciatic nerve was treated directly with staphylococcal filtrates pre­
pared by the method of Dolman et al. (1936) and heat treated to destroy
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alpha and beta toxins, the kymographic effect was found to resemble the 
action of tetanus toxin.
Hemolysins
The main contender with coagulase for primary role as a virulence 
factor is alpha hemolysin, an extracellular product which lyses rabbit, 
and to a lesser degree sheep, but not human red blood cells. Alpha hemo­
lysin is commonly associated with the lethal and necrotizing effects of 
toxic staphylococcal culture filtrates (Elek and Levy, 1950b; Blair, 1958; 
Brown and Scherer, 1958; Johanovsky, 1958a). Several investigators 
claimed that there is a closer correlation between alpha hemolysin pro­
duction and pathogenicity than between coagulase and pathogenicity, and 
some advocated the use of alpha hemolysin rather than coagulase production 
as the ^  vitro criterion for the potential pathogenicity of staphylococci 
(Christie et al., 1946; Marks, 1952; Seluie and Simon, 1952; Fisher and 
Thompson, 1956). Others reported, however, that a varying proportion of 
staphylococcal strains from human lesions produce no alpha hemolysin (Lack 
and Wailing, 1954; Jackson £t^£l., 1955; Lack, 1956; Jessen et al.,
1959a).
Close correlation of alpha hemolysin with coagulase production was
demonstrated by Chapman .et a_l. (1934). With improved methods for the
detection of alpha hemolysin, between 93 and 96 per cent of coagulase-
positive strains were found to produce alpha lysin (Williams and Harper,
1946, 1947; Elek and Levy, 1950b). Elek and Levy (1950b) suggested that
the term "hemolytic staphylococci" be discarded as meaningless because a
high proportion of coagulase-negative staphylococci produce nonspecific 
hemolysis of rabbit and sheep cells. Blair (1958) commented that alpha
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hemolysin per se seems to be of little importance in the pathogenesis of 
staphylococcal infections in man because of its effect on human erythro­
cytes is negligible and some pathogenic strains do not produce it.
A second, serologically distinct hemolysin, beta hemolysin, was 
first demonstrated by Glenny and Stevens (1935). Beta hemolysin lyses 
sheep erythrocytes only, and its activity is enhanced when refrigeration 
follows a 37 C incubation period or by "hot-cold lysis." It has no effect 
on rabbit or human erythrocytes. It is produced chiefly by strains of 
animal origin and is uncommon in human strains (Cowan, 1938; Christie 
and Keogh, 1940; Christie ^  , 1946; Williams and Harper, 1946, 1947;
Elek and Levy, 1950b). Hinton and Orr (1957), however, indicated that 
hospital staphylococcal strains are characterized by the common ability 
to produce beta hemolysin besides their tendency to show a remarkable 
incidence of antibiotic-resistance and they belong in great majority to 
phage group III (Blair, 1956).
Williams and Harper (1947) reported the presence of a third staph­
ylococcal lysin, delta hemolysin, which was not neutralized by either 
alpha or beta antitoxins. It produces a narrow, well-defined zone of 
hemolysis around staphylococcal colonies growing on agar plates which 
contain sheep, rabbit, human, or mouse blood. The delta hemolysin is 
produced by over 90 per cent of the strains isolated from human staphylo­
coccal infections, and in these strains it is usually associated with 
alpha hemolysin. However, it occurs as the only hemolysin in about 4i per 
cent of human strains (Elek and Levy, 1950b, 1954; Marks and Vaughan, 
1950).
Lack and Wailing (1954) doubted if beta and delta hemolysins are
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virulence factors of staphylococci. Johanovsky (1957a) investigated the 
significance of delta hemolysin and noted that neutralization of this 
lysin determined the outcome of staphylococcal infection in experimental 
animals. Jackson and Little (1956, 1957) suggested that the delta lysin 
may be identical with leucocidin. Hunt and Moses (1958) indicated that 
the concentration of delta hemolysin in mouse peritoneal leukocytes may 
be the cause of the abrupt appearance of extracellular staphylococci 
following phagocytosis and the subsequent rapid death of the animal.
The characteristics and relationships of aIpha, beta, and delta 
hemolysins have been described by Elek and Levy (1950b). The superiority 
of the plate over the tube method for the detection of individual hemo­
lysins, due to their differential diffusion rates, was advocated by the 
same workers. This view is strengthened by the observation that alpha 
and beta hemolysins are mutually antagonistic, whereas beta and delta 
hemolysins have a synergistic effect. Differentiation of the three 
hemolysins can best be achieved by a combination of the appearance of 
hemolysis on rabbit, sheep, and human blood agar plates with specific 
antibody neutralization of the hemolysins (Elek and Levy, 1950b, 1954; 
Elek, 1959).
Leucocidin
Pathogenic staphylococci are capable of producing one or more 
leukocyte destroying substances. Gladstone and van Heynigen (1957) 
gave evidence of at least three staphylococcal leucocidins. In addition 
to the Neisser-Wechsberg (Neisser and Wechsberg, 1900; Panton and Valen­
tine 1932) leucocidin, which acts on rabbit leukocytes only and which is 
merely another effect of alpha hemolysin, the authors differentiated two
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other factors. One of these was specific for human and rabbit white 
cells, while the other, "leucolysin," acted on the leukocytes of all 
animal species tested except sheep white cells. They reported that the 
first of these two factors is produced by many coagulase-positive staph­
ylococci, but not by any coagulase-negative strains, whereas leucolysin 
is produced by a large number of coagulase-positive staphylococci and 
by some coagulase-negative strains.
Definite information concerning the exact role of leucocidin in 
the virulence of staphylococci is scarce. It is only recently that a 
partial purification of leucocidin has been accomplished (Woodin, 1959). 
The importance of determining leucocidin activity in evaluating the 
pathogenicity of staphylococci was emphasized by Vancurik and Svejcar 
(1960), who found a high degree of correlation between leucocidin pro­
duction and pathogenicity of the organism.
Enzymes
Staphylokinase. The exhibition of fibrinolytic activity by staph­
ylococci was encountered by early workers. Much (1908) noted that clot­
ting of human blood by staphylococci was followed by dissolution of the 
clot. Fibrinolytic activity is restricted essentially to coagulase- 
positive strains of human origin (Gerheim, 1948). Lack and Wailing 
(1954) reported that, with few exceptions, staphylococci which produce 
beta hemolysin and are chiefly of animal origin fail to produce fibrino- 
lysin. Fisher (1936b) found that approximately 81 per cent of coagulase- 
positive strains dissolved human plasma- or fibrinogen-clots, whereas, 
others reported this figure as 70 per cent (Lack and Wailing, 1954; Lack, 
1956). Fisher (1936b) and Neter (1937) suggested that the potential
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danger of a staphylococcus is greater if it is capable of dissolving the 
fibrin barrier and thus spreading the infection. Small emboli may be 
liberated by fibrinolysin from an affected thrombus, to lodge in the body 
and establish metastasis (Fisher, 1936b; Cruikshank, 1937). There is 
some evidence that streptokinase, by its interaction with plasminogen, 
contributes to the pathogenicity of streptococci for mice; that combina­
tions of certain concentrations of streptokinase and plasminogen increase 
the pathogenicity of fibrinolysin negative staphylococcal strain for mice 
to a greater extent than did either substance alone (Krasner and Young, 
1959). However, little information is available concerning the possible 
role of fibrinolysin in the pathogenesis of staphylococcal infection.
Fisher (1936b) found the active principle, which was responsible 
for the lysis of the fibrin clot, was present in precipitates obtained 
by treating staphylococcal culture filtrates with alcohol. Lack (1948a) 
showed that staphylococcal fibrinolysin was similar to streptococcal 
fibrinolysin and suggested that the active principle is not a true fi­
brinolysin but, rather, a kinase which activates plasminogen. Soybean 
trypsin inhibitor which inhibits plasmin also inhibited staphylokinase 
activity and this observation was used to distinguish the fibrinolysin 
obtained by kinase activation of plasmin from the effect of proteases 
(Lack and Wailing, 1954; Lack, 1956, 1957; Hinton and Orr, 1957).
Hyaluronidase. The majority of pathogenic staphylococci produce 
hyaluronidase, an enzymatic "spreading factor" which attacks the hya­
luronic acid constituent of the intracellular ground substances of 
many body tissues (Schwabacher et al., 1945; Blair, 1958; Lack, 1956). 
Schwabacher ^  £l. (1945) reported that 93.6 per cent of coagulase-
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positive staphylococci produced the enzyme, while none of the coagulase- 
negative strains produced it. Myers (1959) described an ammonium molyb- 
date chemical (AMI) test as an indirect measurement of the amount of 
hyaluronidase produced by staphylococci. Close association between an 
"invasive" type of staphylococcal infection and a positive AMC reaction 
of the infecting strain, led the author to speculate on staphylococcal 
hyaluronidase as an important virulence factor. The exact role of hya­
luronidase in the pathogenicity of staphylococci is, however, not es­
tablished and is a matter of conjecture. Lack (1956) suggested that it 
may serve to remove a potential inhibitor of the organism by depoly- 
merizing hyaluronic acid in connective tissue. Rogers (1956) indicated 
that certain extracellular enzymes, including hyaluronidase, are formed 
at or near the surface of cell and are extruded in the form of a capsule. 
Certain negatively charged synthetic polymers, "macroanions," were found 
to inhibit the production of the enzymes. It was suggested that a similar 
effect may be exerted in the body by natural macroanions such as chon- 
dritin sulfate, hyaluronic acid, heparin or nucleic acids. There is some 
evidence that staphylococcal hyaluronidase may contribute to the severity 
of infections in which staphylococci are mixed with certain other bacteria 
or viruses (Lack, 1948b; Blair, 1958; Elek, 1959). Elek (1959) concluded 
that the presence of the enzyme cannot be correlated with the invasive­
ness of individual strains because it is produced by the great majority 
of coagulase-positive staphylococci; if hyaluronidase does play any role 
at all, it is likely to be effective only in the initial stages of infec­
tion since the earliest inflammatory response of the host suppresses it.
Phosphatase. Phosphatase production by coagulase-positive
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staphylococci and its detection by the use of phenolphthalein phosphate 
agar were described by Barber and coworkers (Barber et , 1951; Barber 
and Kuper, 1951). They reported that after 24 hours incubation coagulase- 
positive staphylococci regularly gave a positive phosphatase test, whereas 
coagulase-negative strains were always negative. The authors, and sub­
sequently White and Pickett (1953) , recommended the use of the phospha­
tase test for the rapid screening of coagulase-positive staphylococci.
A quantitative test for phosphatase activity was reported by Barnes and 
Morris (1957). Shaw et al. (1951) and Elek (1959) observed that a low 
percentage of coagulase-positive staphylococci were phosphatase negative 
and some coagulase-negative strains gave a positive phosphatase test.
The combination of coagulase, mannitol and phosphatase tests was recom­
mended by Capocaccia (1956) as a more reliable index of pathogenicity.
When positive results were obtained, there was a strong indication of the 
organism's potential virulence.
Deoxyribonuclease. Gatlin (1956) demonstrated the synthesis of 
deoxyribonuclease in staphylococci. A rapid method for detecting activ­
ity on nucleic acids of microorganisms grown on a semi-synthetic medium 
was reported by Jeffries et £l. (1957). Subsequent reports (Di Salvo, 
1958; Fusillo and Weiss, 1959) described methods for the demonstration 
and the qualitative estimation of staphylococcal deoxyribonuclease 
(DNase). Weckman and Gatlin (1957) reported that high DNase activity 
is a property of all coagulase-positive staphylococci, whereas all 
coagulase-negative strains have significantly lower DNase activity.
Burns and Holtman (1959) agreed that the ability to split deoxyribo­
nucleic acid appears to be a common characteristic among potentially
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pathogenic strains; that it is lacking in strains of doubtful virulence, 
since there is a good correlation between DNase activity and other prop­
erties of staphylococci (coagulase-positive, pigmentation and mannitol 
fermentation) which are usually associated with virulence.
Egg-yolk reaction. Gillespie and Alder (1952) and Alder ^  al.
(1953) reported on a stable property (Andreoni, 1958), the egg-yolk (EY) 
reaction, which is demonstrable by living cultures of aureus and by 
ammonium sulfate precipitates of staphylococcal culture filtrates. It 
was observed that most strains of coagulase-positive staphylococci pro­
duced an opacity when grown in egg-yolk broth, and a slower, less dis­
tinct, though definite reaction on egg-yolk agar medium in the form of 
zones of opacity around the colonies. Coagulase-negative strains did 
not have this effect. The evidence suggested that the reaction may be 
caused by a lipase which is active against certain triglycerides rather 
than by the general lipolytic activity exhibited by nearly all coagulase- 
positive and many coagulase-negative staphylococci (Christie and Graydon, 
1941; Williams and Harper, 1947). This assumption was subsequently 
supported by Jessen ^  (1959a) who also found almost complete cor­
relation between the EY-reaction and the presence of Tween-splitting 
lipase. Parker (1958) indicated that a perfect correlation existed be­
tween the EY-reaction and the serum opacity which is produced by staph­
ylococci and which is not due to coagulase. Graber et £l. (1958) related 
the EY-reaction to phage typability of staphylococci. Recently, Drummond 
and Tager (1959a,b) observed the production of turbidity when a purified 
preparation of coagulase was incubated with egg yolk. Their analysis of 
this phenomenon resulted in the description of a second biological
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activity for coagulase, that of an esterase, which has a marked specific­
ity for tributyrin.
Lipase. The production of a diffusible staphylococcal lipase, 
which can be demonstrated on solid agar medium, was reported by Davies
(1954). It is formed independently of coagulase, and is widely dis­
tributed among staphylococci. There is, apparently, no correlation be­
tween lipase production and the source of the organism. However, more 
coagulase-positive than coagulase-negative strains were found to form 
the enzyme. Davies (1954) found that lipase activity is present in high 
dilutions in culture filtrates; that the enzyme is antigenic. Elek 
(1959) commented that there is no evidence at the present that lipase 
plays any part in the pathogenicity of staphylococci.
Urease. The production of urease by coagulase-negative staphylo­
cocci and its absence in coagulase-positive strains was claimed by 
Fusillo and Jaffurs (1955). Though the correlation was not complete, 
the authors proposed the use of the urease test for differentiating 
pathogenic from non-pathogenic staphylococci. Fahlberg and Marston 
(1959) reported that urease production by staphylococci is inconsistent 
and Elek (1959) regarded this property to be of no taxonomic value.
Pigment Production and Mannitol Fermentation 
The production of pigment and mannitol fermentation have for long 
been associated with potentially pathogenic staphylococci (Julianelle, 
1937; Chapman et al., 1938; Chapman, 1940). In general, it was accepted 
that the pigmented, coagulase-positive staphylococci fermented mannitol, 
whereas the white, coagulase-negative staphylococci failed to do so. The 
correlation of these two physiological properties and a few others, such
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as salt tolerance, with coagulase production led to the development and 
recommendation of a variety of selective media for the recognition of 
potentially pathogenic staphylococci (Chapman, 1945, 1946; Esher and 
Faulconer, 1959). Recently, Schaub and Merritt (1960) described a broth 
medium containing plasma and mannitol for the simultaneous detection of 
mannitol fermentation and coagulase production by aureus. However, 
discrepancies between mannitol fermentation and coagulase production 
have been reported (Evans, 1947). Evans pointed out that more complete 
correlation existed between anaerobic than aerobic fermentation of 
mannitol and coagulase production. Furthermore, non-pigmented variants 
which are capable of coagulase production have been encountered (Barber, 
1955; Boniece et £l., 1957). The white variants obtained by Barber
(1955) resembled the pigmented parent strains in the elaboration of 
coagulase and in certain other characters, but not in their ability to 
clump in plasma. Rosenblum and Jackson (1957) concluded that a high 
degree of correlation existed between pigmentation, bound coagulase 
(clumping factor) and sensitivity to typing phages in staphylococci 
freshly isolated from routine clinical specimens.
Susceptibility to Antibiotics 
Ingram (1951) found no correlation between certain physiological 
properties of staphylococci, such as pigmentation, beta hemolysin and 
coagulase production, and their susceptibility to penicillin. Nor did 
Amsterdam and Schneierson (1957) observe any distinct relationship be­
tween penicillin susceptibility and virulence of coagulase-positive 
strains of aureus. The same workers found no change in the virulence 
of originally penicillin sensitive strains following their artificial
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induction of resistance to the antibiotic.
Subsequent to the observation of the differential susceptibility 
of staphylococcal strains to neomycin (Greer and Menard, 1957-1958), 
mannitol-neomycin agar medium was described (Greer and Britt, 1959;
Greer and Menard, 1959). It was found that coagulase-negative staph­
ylococci as well as certain other pathogenic bacteria were inhibited 
by concentrations of neomycin which had no effect on coagulase-positive 
staphylococci. The use of mannitol-neomycin agar was recommended by 
these workers as a selective media for the potentially pathogenic staph­
ylococci, especially from skin and nasal specimens.
Phage Typing and Serological Typing
Serological typing, as developed by various investigators (Cowan, 
1938, 1939; Christie and Keogh, 1940; Hobbs, 1948; Brodie, 1957; Lofkvist, 
1957; Ceding, 1952, 1957; Pettison and Mathews, 1957; Stern and Elek,
1957; Ceding and Sompolinsky, 1958; Ceding and Williams, 1958) did not 
prove applicable for routine use in the recognition of potentially patho­
genic staphylococci. No particular serotype of aureus has been asso­
ciated with virulence. Phage-typing on the other hand, has been widely 
and successfully employed in epidemiological studies (Blair, 1956) since 
its development (Fisk, 1942a,b). Only coagulase-positive staphylococci 
are regularly lysed by the specific staphylococcal bacteriophages. 
Borchardt (1953) and Levy ^  al. (1953) could demonstrate no significant 
association between diffusible antigens, hemolysins, fibrinolysin, and 
pigment production with the phage groups of staphylococci isolated from 
human sources. Likewise, Fahlberg and Marston (1959) were unable to es­
tablish any direct relationship between certain groups of phage-typable.
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coagulase-positive staphylococci and the production of aIpha, beta or 
delta hemolysins. Several unsuccessful attempts have been made to re­
late staphylococcal serotypes and phage types (Oeding and Sompolinsky, 
1958). Barber and Wildy (1958), however, related the antigenic spec­
ificity of coagulase to the bacteriophage group of the staphylococcus.
Relationship of ^  vitro Staphylococcal Antigen- 
Antibody Reactions to Virulence 
Elek and Levy (1950a) used a double diffusion gradient method to 
estimate the number of diffusible antigens of staphylococci obtained 
from various sources. The mean number of precipitation lines of antigen- 
antibody reactions was greatest with strains isolated from human lesions. 
All coagulase-positive strains from lesions produced antigens and this 
suggested to the authors that these diffusible substances are prerequi­
sites of virulence. Animal strains, and on the average strains from 
nasal carriers, showed fewer antigens, but the majority of the latter 
group resembled those from lesions. Nasal strains deficient in antigens 
were also poor in hemolysins production. Howard (1954) found the number 
of antigen-antibody flocculation lines is directly related to the mouse 
virulence of different staphylococcal strains when the mice are inoculated 
by the intramuscular method of Selbie and Simon (1952). The number of 
lines varied from eight in the most virulent to zero in the avirulent 
strains. Similar results were reported by Anderson (1956). In their 
study of the factors which may contribute to pathogenicity. Lack and 
Wailing (1954) found that greater pathogenicity was associated with a 
broad spectrum of toxins rather than with greater production of any one 
toxin. Hinton and Orr (1957) investigated the distribution of toxins in
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coagulase-positive staphylococci isolated from patients and carriers.
They found that strains from furuncles and carbuncles produce more 
diffusible antigens, alpha and delta hemolysin, as well as staphylo- 
kinase than did strains isolated from wound infections. However, all 
of these strains were more active in these respects than those strains 
isolated from throats of the same patients. The authors considered the 
production of alpha and beta hemolysins and staphylokinase as character­
istic of the more virulent strains. Recently, Thomas and Penikett (1959) 
were unsuccessful in their attempt to grade hospital coagulase-positive 
staphylococci on the basis of identifiable properties and number of 
diffusible antigens.
Host Factors and Pathogenesis of 
Staphylococcal Disease 
It is evident, from the wide distribution of staphylococci in the 
environment and on body surfaces, that man is, ordinarily, relatively 
resistant to staphylococcal infections. The studies of Elek (1956) dem­
onstrated that, regardless of the source or toxigenicity of the organism, 
a minimal infecting dose of 2 to 7 million staphylococci was necessary 
to produce a purulent lesion in the skin of human volunteers. The effect 
of subinfectious doses was not enhanced by plasma, toxin, starch, or 
mucin. The infective capacity of the staphylococci was, however, en­
hanced 500 to 10,000 fold by the presence of foreign bodies such as su­
tures (Elek, 1956; Elek and Conen, 1957).
Susceptibility to infection by staphylococci appears to be influ­
enced by certain consititutional factors and to be markedly altered by 
nutritional disturbances and certain debilitating diseases (Elek, 1959).
45
Smith and Dubos (1956b) found that when mice were completely deprived of 
food for 36 to 48 hours immediately before infection, their susceptibility 
to staphylococcal infection was increased. This effect was enhanced by 
allowing the animal to drink 5 per cent glucose solution instead of water 
or saline during the fasting period. Mice fed inadequate diet for several 
weeks appeared to be just as resistant to staphylococcal infections as 
did mice which gained weight rapidly on unrestricted, complete diet. 
However, when mice were maintained on a diet containing non-lethal but 
weight retarding amounts of dinitrophenol or thyroid extracts for one or 
two weeks before infection. Smith and Dubos (1956c) found that most of 
them died within 12 days after infection with staphylococci, and much 
more rapidly than mice fed a normal diet. Deaths occurred even when the 
organism injected was ordinarily a non-virulent staphylococcus, unable 
to cause fatal disease in mice fed a normal diet.
Prigal and Dubos (1956) reported that when mice, which had pre­
viously been sensitized to bovine serum, were injected intravenously with 
staphylococci, many more organisms were recovered from the kidneys, liver 
and lungs of these animals than from the same organs of similarly in­
fected, non-sensitized mice, Johanovsky (1958b) reported that a state 
of increased susceptibility to staphylococcal infection together with 
the delayed hypersensitivity to staphylococcal antigens can be trans­
ferred to normal rabbit recipient by means of living cells in spleen 
homogenate. A non-lethal substance, probably nucleoprotein, which is 
present in extracts of pathogenic staphylococcal cells and which is un­
related to the extracellular products found in culture filtrates, may 
be the toxic or allergenic factor (Dworetzky et al., 1956).
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Purpose of the Present Investigation 
From the preceding survey it is obvious that several properties of 
staphylococci are associated with their ability to produce coagulase and 
directly or indirectly with their virulence. Several classifications 
were proposed in an attempt to differentiate pathogenic from non-patho- 
genic staphylococci (Shaw et £l., 1951; Cowan and Shaw, 1954; Thatcher 
and Simon, 1957); however, the production of coagulase appears to be the 
most widely accepted criterion for the detection of potentially patho­
genic staphylococci (Blair, 1958; Elek, 1959). In the seventh edition 
of Bergy's Manual of Determinitive Bacteriology (Breed ^  , 1957)
staphylococci are divided into two species on the basis of two main prop­
erties: coagulase production and mannitol fermentation. Accordingly,
if both of these tests are positive, the organism is assigned the name 
Staphylococcus aureus ; if both are negative, the organism is named 
Staphylococcus epidermidis.
The chief purposes of the present investigation were:
1. To modify and evaluate the use of a soft agar medium for the simul­
taneous demonstration of staphylococcal coagulase and clumping factor 
activities.
2. To compare the mouse virulence of ordinary strains of staphylococci 
with that of rare strains which exhibit either coagulase or clumping 
factor activity but not both of these properties.
3. To investigate the effect of the route of injection on the mouse 
virulence and infectivity of these staphylococcal strains.
4. To determine if other vitro properties of the selected strains of 
staphylococci could be correlated with their virulence and infectivity 
for mice.
47
5. To observe the effect of vivo cultivation on the properties of 





More than 350 strains of staphylococci were examined by a variety 
of methods for their coagulase and clumping factor properties. The great 
majority of the strains tested were isolated from hospital patients and 
personnel; a few were laboratory stock cultures. Two additional strains, 
the Smith strain (S) and its mouse virulent variant (Sv), were kindly 
supplied by Dr. George A. Hunt of Bristol Laboratories.
All strains were maintained on trypticase soy agar (Baltimore 
Biological Laboratories) slants at 4 to 6 C and were transferred at 
monthly intervals. Periodic observations were made for homogeneity of 
the cultures by plating them on blood trypticase soy agar. Similarly, 
single colony isolates, which were typical of each strain, were main­
tained and checked at regular intervals for stability of coagulase and 
clumping factor activities. The single colony isolates were used in the 
virulence studies and in determination of properties usually associated 
with the pathogenicity of staphylococci. Strains selected for such 
studies possessed both coagulase and clumping factor, coagulase or clump­
ing factor, or neither of these properties.
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Strains Positive for Coagulase and Clumping Factor 
Four strains selected for study were positive for both coagulase 
and clumping activity. These were the Smith parent (S), Villafor (V), 
Hutton (H) and Steward 33 (S 33) strains. The Smith strain was origi­
nally isolated from a human case of osteomyelitis in 1930 by Dubos and 
later was briefly described by Smith and Dubos (1956a). The Villafor 
strain was isolated in 1959 from the blood of a terminal leukemia patient. 
The Hutton strain is a recent isolate from a throat culture of a healthy 
carrier. The Steward 33 strain originated in an infected leg wound; it 
was held in the frozen state (-28 C) for more than two years before the 
present study began.
Strains Positive for Coagulase and 
Negative for Clumping Factor 
Four of the 13 strains selected for study, the Smith mouse virulent 
variant (Sv), K 6, K 93 and K 93m, were unusual in that they possessed 
coagulase but no clumping factor activity. Isolation of the mouse viru­
lent variant of the Smith strain was reported by Hunt and Moses (1958). 
The unusual character of two strains, obtained from clinical specimens 
taken from patients at local hospitals, were noted in this laboratory. 
Strain K 6 was isolated from a nasopharyngeal swab. K 93 originated in 
a mixed culture from an ulcer on the foot of a patient. K 93m is a 
mucoid variant of the K 93 strain; it was recovered from organs of mice 
which were sacrificed five weeks after intravenous injection with the 
K 93 strain. Each organism of this strain appears to be surrounded by 
an envelop of mucoid material which is less discreet than the usual 
bacterial capsule.
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Strains Negative for Coagulase and 
Positive for Clumping Factor 
Staphylococci which do not produce coagulase but which exhibit 
clumping factor activity are probably even more rare than those which 
are negative for clumping factor and positive for coagulase. Three 
such rare strains, recognized in this laboratory, Hv 1, S 35 and S 35s, 
were included in the study. The Hv 1 strain first appeared as a coagu- 
lase-negative variant in a soft agar culture of the coagulase-positive, 
clumping factor-positive H strain. Strain S 35 was coagulase-negative, 
but clumping factor-positive, and its growth was noticeably rough when 
it was first isolated from a bronchoscopy specimen. The strain desig­
nated S 35s is a smooth variant of the S 35 strain. This smooth variant 
was recovered from the organs of mice injected with the parent strain.
It differs from the parent organism not only in its smooth type growth, 
but also in the formation of larger compact colonies in fibrinogen con­
taining soft agar.
Strains Negative for Coagulase and Clumping Factor 
Two strains selected for further study were Hv 2 and S 33v, in 
vitro variants of the H strain and S 33 strain respectively, which were 
distinguished from the parent organisms in soft agar cultures by their 
lack of both coagulase and clumping factor activity.
Demonstration of Coagulase and Clumping Factor
Conventional Methods 
The production of coagulase was demonstrated by the routine plasma 
clotting test. Rehydrated compounded plasma (Difco) was inoculated with
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12 to 16 hour broth cultures of the organisms and incubated at 37 C. The 
tubes were observed for clotting at the end of 1, 3 and 24 hours incuba­
tion.
Clumping factor activity was determined simultaneously by the slide 
and tube agglutination methods (Duthie, 1954a). In each procedure, an 
equal volume of a saline suspension of the organism was mixed with (a) 
undiluted fresh human pooled plasma, (b) rehydrated compounded plasma 
(Difco) and (c) a saline solution of 0.4 per cent bovine fibrinogen 
(Armour fraction I), a common concentration of fibrinogen in normal human 
plasma (Miller, 1957). Slide tests were considered to be positive if 
visible clumping of the organisms occurred within 15 to 30 seconds. In 
cases of delayed or no clumping in the slide test, a loop of growth from 
a 16 to 18 hour trypticase soy agar slant culture was emulsified directly 
in a drop of undiluted plasma and in the fibrinogen-saline; the slides 
were observed for the same time interval. In the tube agglutination test, 
readings were made after mixtures of the cell suspension and plasma or 
the cell suspension and fibrinogen solution were shaken vigorously on a 
Kahn shaker for five minutes.
The Soft Agar Method
Media devised for simultaneous detection of coagulase and clumping 
factor. During the course of these studies a new soft agar medium was 
developed to demonstrate both coagulase and clumping factor in a single 
system (Alami and Kelly, 1959). Preliminary observations were made on 
(a) the nature of the growth of approximately 350 strains of staphylo­
cocci in a basal soft agar medium and (b) the effect on the growth of 
the organisms on the addition of varying amounts of sterile plasma, serum.
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fibrinogen or albumin or combinations of these substances to the basal 
medium. For each strain, results of the usual plasma clotting coagulase 
test and slide agglutination in plasma and in fibrinogen were compared 
with the type of colonies observed in the various soft agar media. The 
method which proved to be most satisfactory as to correlation of results 
required (a) a basal soft agar medium made by adding 0.15 per cent agar 
to trypticase soy broth (BBL) , (b) fibrinogen soft agar which incorporates 
0.4 per cent bovine fibrinogen (Armour fraction I) in the basal medium, 
and (c) fibrinogen-plasma-albumin soft agar which has a final concentra­
tion of 1 per cent pooled human plasma, 0.4 per cent bovine fibrinogen, 
and 0.3 per cent bovine albumin (Armour fraction V), added to the basal 
medium.
For convenience the basal medium was prepared in two different agar 
concentrations: a 0.15 per cent agar and a 0.3 per cent agar medium.
The former was dispensed in 10 ml amounts and the latter in 5 ml amounts 
to 1.5 X 12 cm screw capped tubes before autoclaving. To make 0.4 per 
cent fibrinogen soft agar, 0.8 per cent solution of fibrinogen in trypti­
case soy broth was sterilized by positive pressure Seitz filtration and 
added in 5 ml amounts to tubes containing 5 ml melted, cooled, 0.3 per 
cent agar basal medium. In the third type of medium, either rabbit or 
human plasma proved to be satisfactory source of the necessary coagulase 
reacting factor (CRF). The practice of pooling several lots of human 
plasma routinely employed here was a precaution against the presence of 
a high concentration of staphylococcal antibodies in any one plasma. A 
solution of 3 per cent albumin in trypticase soy broth was sterilized by 
positive pressure Seitz filtration before it was incorporated at 0.3 per
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cent final concentration in the plasma-fibrinogen soft agar.
Inoculation of soft agar media. An inoculum which resulted in an 
appropriate number of colonies, e., 20 to 50 per tube of soft agar 
medium was obtained as follows. For each strain to be tested, a tube 
containing 5 ml trypticase soy broth was inoculated from an overnight 
trypticase soy agar slant culture. After 4 to 6 hours incubation at 
37 C, the young broth culture was diluted serially using a 4 mm loop to 
introduce the organisms successively to (1) 10 ml sterile saline con­
taining 0.05 per cent peptone, (2) 3 ml of the same sterile peptone- 
saline and (3) 10 ml of the soft agar medium. In this manner each cul­
ture to be tested for coagulase and clumping factor activity was inocu­
lated to a tube of fibrinogen-plasma-albumin soft agar as well as to 
tubes of the two control media: the basal soft agar and the fibrinogen
soft agar.
When a primary plate culture of the staphylococci recovered from 
infected mice was to be tested, a sufficient amount of the growth was 
taken from the confluent area to make a turbid suspension in 2 ml of 
sterile trypticase soy broth. A loop of this suspension could then be 
substituted for the young broth culture to make the serial dilutions 
described above.
All soft agar cultures were examined after 12 to 16 and 24 hours 
incubation at 37 C.
Titration of Coagulase
Because filtration of broth cultures of coagulase-positive staph­
ylococci removed much, if not all, of the coagulase activity, titration 
of coagulase was next attempted with supernatants of centrifuged broth
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cultures. This method, although fairly satisfactory, proved cumbersome. 
The method finally followed was the one advocated by Lominski (1944) who 
discovered that the incorporation of serum into the culture medium enables 
coagulase to pass through Seitz filters.
Five ml amounts of sterile brain heart infusion (Difco) which con­
tained 10 per cent of pooled human serum were inoculated from stock agar 
slant cultures of the organisms. After eight hours incubation at 37 C, 
0.05 ml of the young serum-broth culture was transferred to a tube of 10 
ml sterile serum-broth and this tube was incubated at 37 C for 18 hours. 
The culture was then centrifuged for 20 minutes at 2500 rpm. The super­
natant was passed through a Boerner type Seitz filter. Two-fold serial 
dilutions of the sterile filtrate were made in 1 x 9.5 cm tubes contain­
ing 0.5 ml of sterile trypticase soy broth. Next, 0.5 ml of the same 
clotting system used in the soft agar method, _i-_e. , a sterile mixture of 
1 per cent pooled human plasma, 0.4 per cent fibrinogen and 0.3 per cent 
albumin in trypticase soy broth, was added to each tube. The tubes, with 
appropriate controls, were incubated at 37 C and were examined for clot 
formation at five minute intervals during the first hour, at 15 minute 
intervals for the next four hours, every hour for the following five 
hours and, finally, after 24 hours incubation. The amount of coagulase 
in the culture filtrate was graded on the basis of the highest dilution 
of the filtrate which caused clot formation and the time required to form 
the first clot in the dilutions of each filtrate.
Titration of Clumping Factor
The organisms were tested for clumping factor activity in decreas­
ing concentrations (0.4, 0.2, 0.1, 0.05, 0.02 and 0.002 per cent) of
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bovine fibrinogen (Armour fraction I) by the slide and the tube agglu­
tination methods, as well as for their ability to form compact colonies 
in the basal soft agar medium containing similar decreasing concentra­
tions of fibrinogen. Equally turbid saline suspensions of each strain 
were prepared for the slide and tube agglutination tests from 18 hour 
trypticase soy agar slant cultures. Fibrinogen agar was inoculated as 
described above. Included in the slide and agglutination tests were 
saline controls which ruled out auto-agglutination and other controls 
which gave the expected results with known clumping factor positive and 
negative strains (Cadness-Graves ^  al., 1943; Duthie, 1954a; Steward 
and Kelly, 1959). A basal soft agar medium culture was included as a 
control for the fibrinogen-soft agar test. The amount of clumping factor 
present was judged in the slide and tube agglutination procedures by the 
highest dilution of fibrinogen in which clumping of the organisms oc­
curred; in the case of the soft agar method, it was indicated by the 
highest dilution of fibrinogen which supported the formation of compact 
colonies.
Further Characterization of Staphylococcal Strains 
In addition to coagulase and clumping factor, the organisms were 
also examined for other iji vitro properties which have been associated 
with typical aureus strains, coagulase production and staphylococcal 
virulence (Blair, 1939, 1958; Evans, 1948; Elek and Levy, 1950a; Shaw et 
al. , 1951; Cowan and Shaw, 1954; Hinton and Orr, 1957; Thatcher and Simon, 
1957; Jessen ^  al., 1959a,b).
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Pigmentation
Pigment production was observed in plate cultures of milk agar 
which were incubated at 37 C for 18 to 24 hours and then held at room 
temperature for at least one week (Fujita and Yoshioka, 1923, 1938; 
Christie and Keogh, 1940; Anderson, 1936). Milk agar was prepared by 
adding autoclaved fresh skim milk to an equal volume of sterile, melted 
trypticase soy agar (3.0 per cent agar) medium.
Catalase
The test for catalase was performed by suspending a loop of the 
growth from an 18 to 24 hour trypticase soy agar culture in 3 per cent 
hydrogen peroxide. Bubbling indicated a positive test.
Mannitol Fermentation
Aerobic phenol red mannitol agar (Difco) as well as aerobic and 
anaerobic phenol red mannitol broth (Difco) cultures of each strain were 
incubated at 37 C for 48 hours. A positive fermentation test was evi­
denced by change of the indicator color from red to yellow. Plate cul­
tures of Staphylococcus Medium No. 110 (BBL) were also streaked with 
each strain. After jbic incubation at 30 C for 48 hours, phenol red 
indicator was applied at the site of confluent growth and change in color 
of the indicator was noted.
Hemolysins
A young (10 hour) trypticase soy agar culture of each strain was 
inoculated to produce a band of growth on plates of human, rabbit and 
sheep 5 per cent blood agar. In each instance the blood agar was pre­
pared by adding a saline suspension of washed erythrocytes to trypticase
57
soy agar. All plates were examined after 24 hours incubation at 37 C.
The sheep blood agar plates were incubated an additional 24 hours in the 
cold (4 C) in order to demonstrate the hot-cold lytic effect of beta 
hemolysin. Incubation of the human and rabbit blood agar plates was con­
tinued at 37 C for another 24 hours before a second reading was made.
The occurrence and appearance of hemolytic zones were noted and inter­
preted as to the presence of alpha, beta and delta hemolysins (Williams 
and Harper, 1947; Elek and Levy, 1954; Howard, 1954; Lack and Wailing, 
1954; Blair, 1958; Elek, 1959). Similarly mouse blood agar plates were 
inoculated, incubated and examined.
Phosphatase
The method followed to detect phosphatase was essentially the one 
described by Barber and Kuper (1951). A 0.01 M solution of the substrate, 
phenolphthalein diphosphoric acid (Sigma Chemical Co.), was prepared in 
phosphate buffered saline and was adjusted to pH 7.4. This stock solu­
tion was passed through a Seitz filter and stored in the refrigerator 
when not in use. The phenolphthalein diphosphoric acid agar plates were 
prepared by adding, aseptically, one part of the stock solution to 49 
parts of melted, cooled trypticase soy agar. The cultures were streaked 
in the usual manner or by band streaks which allowed the testing of 
several strains on each plate. After 16 to 18 hours incubation at 37 C, 
the agar surface of each plate was held over an open bottle of aqueous 
ammonia. If the organisms produced sufficient phosphatase to liberate 
phenolphthalein, exposure to ammonia caused the growth to become bright 




Urea broth (Difco) was inoculated from an 18 to 24 hour trypticase 
soy agar culture. The tubes were examined after 12, 24, 48 and 72 hours 
incubation at 37 C. A positive reaction was indicated by the production 
of red color in the culture medium.
Deoxyribonuclease
Deoxyribonuclease (DNase) activity was determined according to the 
method of Di Salvo (1958). The medium used was trypticase soy agar which 
contained 2 mg of DNA (Nutritional Biochemical Corporation) per ml and 
0.8 mg of anhydrous calcium chloride per ml. Six to 8 strains were band 
streaked on each plate of the autoclaved medium and the cultures were 
incubated for no longer than 36 hours at 37 C. The DNase activity was 
demonstrated by flooding the plates with 6 N HCl, which was found more 
satisfactory than the 1 N HCl recommended by Di Salvo. A positive reac­
tion was indicated by a clear zone surrounding the inoculated area and 
the width of this zone was Interpreted as an expression of the amount of 
extracellular DNase produced (Jeffries et al^. , 1957).
Staphylokinase
The method used to detect staphylokinase activity has been recom­
mended by a number of workers (Christie and Wilson, 1941; Lack and Wail­
ing, 1954; Lack, 1956, 1957; Elek, 1956; Hinton and Orr, 1957). The 
fibrin agar plates were prepared by adding pooled human blood bank plasma, 
in a final concentration of 15 per cent, to melted trypticase soy agar 
which had been cooled to 56 C and then holding the medium in a 56 C water 
bath for 20 minutes before pouring into plates. Fibrin agar plates
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containing crystalline soy bean trypsin inhibitor (Nutritional Biochemi­
cals Corporation) in a final concentration of 1:10,000 were also pre­
pared in the same manner. Six to 8 strains were spot inoculated to a 
plate of fibrin agar and to a plate of the soy bean trypsin inhibitor- 
fibrin agar. Plates were incubated at 37 C. Fibrinolytic activity was 
evidenced by the appearance of a clear zone around the growth after 24 
to 48 hours incubation. Soy bean trypsin inhibitor prevents lysis of 
fibrin by staphylokinase-activated plasmin but does not affect the 
fibrinolytic activity of bacterial protease (Lack and Wailing, 1954; 
Lack, 1957). Thus, since staphylokinase producing strains induce clear­
ing only in the absence of soy bean trypsin inhibitor, it was possible 
to distinguish fibrinolysis caused by staphylokinase activation of 
plasmin from that caused by proteases.
Egg-Yolk Reaction 
Each strain was studied for the changes it produced in an egg-yolk 
medium. Egg-yolk agar was prepared according to the directions given in 
the Manual of Microbiological Methods (Conn, 1957). Fresh egg yolk was 
collected aseptically and was diluted with an equal volume of sterile 
normal saline. Ten ml of the yolk suspension was added to each 100 ml 
of melted, cooled trypticase soy agar and the medium was poured into 
sterile plates. The plates were spot inoculated from young (10 hour) 
trypticase soy agar slant cultures and, after 24 and 48 hours incubation 
at 37 C, were examined for a zone of opacity and/or clearing around each 
spot of growth. The formation of a zone of opacity indicated the posi­
tive egg-yolk (EY) reaction of Gillespie and Alder (1952) or, possibly, 
the tributyrinase activity of coagulase described by Drummond and Tager
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(1959a,b); a clearing zone, such as that observed by Graber (1958), may 
represent general lipolytic or lipoproteolytic activity.
Lipase
Demonstration of extracellular lipase was accomplished by the method 
of Davies (1954). Nile blue sulfate-fat agar was prepared by adding a 
hot, distilled water suspension of neutral hog fat (lard) in a final con­
centration of 0.3 per cent to trypticase soy agar which contained 0.1 per 
cent nile blue sulfate. The plates were spot inoculated with each of the 
staphylococcal strains, incubated at 37 C and examined daily for three 
days. Positive results were indicated by the appearance of blue droplets 
on and around the spot of growth due to the liberation of fatty acids.
Phage Typing
The staphylococci were phage typed by the method of Blair and Carr 
(1953, 1960) using the set of 25 staphylococcal phages originally supplied 
by Dr. J. E. Blair. A young (4 to 6 hours) trypticase soy broth culture 
was swabbed over the entire surface of the trypticase soy agar in a cross 
hatched petri plate. A drop of the routine test dilution of each of the 
high titered phage filtration was applied to the appropriate square on 
the plate. Plates were examined for lysis after 18 to 24 hours incuba­
tion at 30 C.
Susceptibility to Antibiotics and Other 
Chemotherapeutic Agents
A blood agar plate was inoculated heavily and uniformly with a 10 
hour trypticase soy broth culture of each strain of staphylococci. Sensi- 
discs (BBL) of the following agents, using high and low concentrations in
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most instances, were placed on the surface of the plates: penicillin,
dihydrostreptomycin, chloramphenicol, tetracycline, chlortetracycline, 
erythromycin, neomycin, kanamycin, Albamycin^^), vancomycin, triacetylo- 
leandomycin, polymyxin B, bacitracin, Spontin(^), triple sulfa, Gan- 
tricin^B^, and Furadantin^^\ Plates were examined for zones of growth 
inhibition after 24 hours incubation at 37 C.
Capsule Stain
The mucoid (K 93m) strain of staphylococci was stained by both the 
Hiss and Anthony capsule staining methods as described in the Manual of 
Microbiological Methods (Conn, 1957). More satisfactory results were 
obtained when the same methods were modified by gently heating the pre­
parations for five minutes while the slides were flooded with the basic 
dye. Several non-mucoid strains of staphylococci, including K 93, K 6 
and S, were subjected to the same capsule stains.
Virulence Studies 
Animals
Equal numbers of male and female albino mice, aged 6 to 8 weeks 
and weighing from 20 to 30 grams, purchased from the National Laboratory 
Animal Company, Creve Cour, Mo., were used throughout the study. The 
animals were fed Rockland mouse diet.
Quantitative Estimate of Viable 
Numbers of Staphylococci
Viable counts of broth cultures and phosphate buffered saline sus­
pensions of staphylococci were estimated by making ten-fold serial
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dilutions in sterile, phosphate-buffered saline and inoculating trypti­
case soy agar plates in triplicates with 1.0, 0.5, and 0.1 ml amounts of 
each of two or three suitable dilutions. After 48 hours incubation at 
37 C, colony counts were made of those plate cultures which developed 20 
to 300 colonies and from this data the viable unit counts were determined.
Additional counts were made by inoculating tubes of soft agar, (in 
each instance the basal soft agar, fibrinogen soft agar and fibrinogen- 
plasma-albumin soft agar) with measured amounts of suitable dilutions.
The soft agar cultures also served to demonstrate the homogeneity of the 
population in the culture with respect to coagulase and clumping factor 
activity.
Preparation of Inoculum
Staphylococci were grown in trypticase soy broth (BBL) for 8 to 10 
hours at 37 C and 0.5 ml of this culture was transferred to 125 ml of the 
same medium contained in 250 ml centrifuge bottles. These cultures were 
incubated at 37 C for 20 to 24 hours. The number of bottles inoculated 
differed with the strain and was determined by previous results of viable 
counts obtained with similar preparations of each strain. The cultures 
were centrifuged for 40 minutes at 2000 rpm. The sediment in each bottle 
was suspended in 25 ml of phosphate-buffered saline and the suspensions 
of cells from the same strain were pooled. The pool of cells was recen­
trifuged and the process of washing the cells with phosphate-buffered 
saline was repeated twice. Finally, the cells were suspended in the 
appropriate amount of phosphate-buffered saline to obtain a challenge 
dose of high count in a volume of 0.3 ml. A preliminary estimate of the 
desired concentration of cells was determined, for each strain, by trial 
inoculations of mice.
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Determinations of LD50 and ID^q 
For each of the 13 strains of staphylococci, five suitable four­
fold dilutions were prepared in phosphate-buffered saline from the washed 
cell suspension described above. A 0,3 ml dose of each of the five dilu­
tions was injected intravenously into each of six mice (three males and 
three females) and intraperitoneally into another group of six mice. The 
viable number of bacteria in each dose was determined as previously des­
cribed immediately after the injection procedure. As controls, groups of 
six mice were injected intraperitoneally and intravenously with 0.3 ml 
amounts of (1) phosphate-buffered saline, (2) sterile trypticase soy 
broth, (3) a sterile supernatant of a trypticase soy broth culture of 
each strain and (4) a heat killed (75 C for 45 minutes) cell buffered 
saline suspension of the highest challenge dose of each strain.
The mice were observed for an experimental period of 14 days (Smith 
and Dubos, 1956a; Gray et , 1957; Gorrill, 1958) and the time of death 
was recorded. On death, the mice were autopsied and cultures were made 
of organs and body fluids as described below. Mice surviving the experi­
mental period were chloroformed and examined immediately for infection 
both grossly and microscopically. The ID5Q was based on recovery of 
culturable staphylococci from dead and sacrificed mice. The Reed-Muench 
method (1938) was followed to estimate the DD^g and ID^q of each staphylo­
coccal strain.
Recovery of Staphylococci from Infected Mice 
Peritoneal fluid, heart's blood and, if present, pus from abscess 
were streaked on blood trypticase soy agar plates. The kidneys, liver, 
spleen and lungs were removed aseptically and impression inoculations
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were made by pressing the cut surfaces of the organs to the surface of 
blood agar plates. At least one whole kidney from each animal was ground 
with 2 ml of phosphate-buffered saline in a small sterile mortar. Oc­
casionally, as a check on the impression inoculation method, homogenates 
of other organs were also prepared. A 4 mm loop of the organ homogenate 
was streaked on a blood agar plate. After incubation, plate cultures 
were examined for purity, colonial morphology and the relative numbers 
of colonies which developed from similar inocula (Braude al-j 1959).
The same amount of the homogenate, suitably diluted, served as an inocu­
lum for soft agar cultures which revealed the coagulase and clumping 
factor activities of the culture population.
Tissue Sections
Sample specimens of organs from normal and infected mice were fixed
in 10 per cent formalin. The tissues were imbedded in paraffin, sectioned
at 4 mm and stained by the Harris hematoxylin-eosin method. These sec­
tions were prepared by Miss Lucy Pitts and they were examined by members 
of the Department of Pathology.
Studies of in vivo Strain Stability 
The in vivo stability of the 13 staphylococcal strains, with special
reference to coagulase production and clumping factor, was studied by
injecting mice with at least two sublethal but infective doses of the 
organisms. For each dose a group of six mice were injected intravenously 
and another similar group intraperitoneally. At two week intervals for 
a period of six weeks, two mice from each group were sacrificed and the 
organisms were recovered as previously described. Colonial morphology
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was observed on blood agar plates and the homogeneity of the mouse passed 
strains as to coagulase and clumping factor activity was tested by the 
soft agar culture method. In like manner, these characteristics were 
examined in organisms recovered from mice which survived the 14 day 
period of the second LD^q and ID50 determinations.
CHAPTER III
RESULTS
The Soft Agar Technique for the Simultaneous Detection 
of Staphylococcal Coagulase and Clumping Factor 
Of the 320 strains reported (Table 1), 240 were positive for coagu­
lase and 80 were negative according to the routine plasma clotting test. 
Results of the slide and tube agglutination tests with 0.4 per cent fibri­
nogen, rehydrated plasma, and human plasma agreed. All morphologically 
typical strains of staphylococci tested produced an elongated, feathery 
type of colonial growth in basal soft agar (0.15 per cent agar) medium.
On the addition of either 1 per cent plasma or 0.4 per cent fibrinogen 
to basal soft agar medium, the great majority of coagulase-positive staph­
ylococci formed compact colonies, whereas the colonies of coagulase- 
negative strains were the same elongated, diffuse type like observed in 
the basal soft agar medium. Preliminary experiments indicated that an 
agar concentration of 0.15 per cent is optimal and minor increase or 
decrease in its concentration affected the characteristic colonial morpho­
logy in basal soft agar, fibrinogen soft agar and in plasma soft agar. 
With rare exceptions, all strains which formed compact colonies in 1 per 
cent plasma soft agar also produced the same type colonies in 0.4 per 
cent fibrinogen soft agar after 14 to 24 hours incubation at 37 C. Con­
versely, strains which failed to develop compact colonies in fibrinogen
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TABLE 1
CLUMPING REACTION AND COMPACT COLONY FORMATION BY COAGULASE- 
POSITIVE AND COAGULASE-NEGATIVE STAPHYLOCOCCI


















240 Coagulase- 208 f 208 + 208 + 217 + 225 + 239 -
Posltlve Strains 4 " 4 - 4 - 3 - 3 - 1 4*
28 28 + 28 ± 8 ±
12 +/-b 12 +/-
80 Coagulase- 3 + 2 + 2 + 3 + 2 + 80 -






77 - 78 -
<T>
'.J
Doubtful results; rough strains In agglutinations; compact, slightly elongated base In soft
agar.
^x/-, mixtures of compact and diffuse colonies In soft agar.
68
soft agar were negative for this feature in plasma soft agar.
Among the 240 coagulase-positive strains, four strains gave nega­
tive slide and tube agglutination tests, and three of these (Sv, K 6 and 
K 93) formed the diffuse type colony in fibrinogen soft agar and plasma 
soft agar (Table 1). The fourth strain (K 93m) is a mucoid variant of 
one of these three strains. Within the first 24 hours incubation, it 
produced large, spherical colonies in fibrinogen soft agar and plasma 
soft agar as well as in the control basal soft agar medium. However, 
these colonies exhibited slight diffusion in all soft agar media after 
an incubation period of more than 24 hours.
Twenty eight of the 240 coagulase-positive strains were autoagglu- 
tinating and gave equivocal results in the slide and tube agglutination 
tests. Twelve of these strains proved to be mixtures of diffuse and com­
pact colonies in plasma soft agar and in fibrinogen soft agar cultures,
, mixtures of clumping factor negative and clumping factor positive 
organisms, respectively. On subsequent isolation and purification of 
these mixed cultures, the diffuse type colonies were found to be negative 
for coagulase activity, whereas the compact type colonies were coagulase- 
positive. Eight of the 28 strains produced compact colonies in plasma 
soft agar, but in 0.4 per cent fibrinogen soft agar they formed an inter­
mediate type colony which was compact and spherical except for slight 
elongation of its under surface.
Of the 80 coagulase-negative strains reported in Table 1, 12 strains 
were doubtful for clumping factor by the slide and tube agglutination 
tests, but these strains produced diffuse colonies in fibrinogen soft 
agar and plasma soft agar. Two other strains were positive in all tests
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for the clumping factor. One strain clumped only in 0.4 per cent or 
more fibrinogen, regardless of the test method and thus proved to be 
notably deficient in clumping factor activity compared to other strains.
When strains were compared in soft agar which contained varied con­
centrations of plasma, serum or fibrinogen, the great majority formed 
compact colonies in 0.4 per cent fibrinogen soft agar, in 0.1 per cent 
plasma soft agar, and in 1 per cent serum soft agar (Table 2). In the 
case of a very few strains, such as the one described above, a higher 
concentration, at least 0.4 per cent, of fibrinogen was required for 
compact colony formation.
For expression of coagulase activity in soft agar, a combination 
of plasma (or serum) and fibrinogen was required in the medium. Well 
defined, opaque, coagulation zones were observed around colonies of 
coagulase-positive strains growing in 1 per cent plasma-0.4 per cent 
fibrinogen soft agar (Figure 1). Substitution of the same concentration 
of normal rabbit serum or plasma for human serum or plasma in these experi­
ments yielded similar results. The addition of 0.3 per cent albumin to 
the system intensified the coagulation zone reaction and supplied a 
highly satisfactory medium for demonstrating both clumping factor and 
coagulase activity, provided a 0.4 per cent fibrinogen soft agar medium 
was also inoculated as a control. An additional control culture of 
basal soft agar medium proved necessary when testing the mucoid strain.
The soft agar method revealed a few staphylococcal strains which were 
positive for one of these properties exclusively and several strains 
which were mixed populations with regard to clumping factor or coagulase 
activity (Table 1; Figure 2).
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TABLE 2
EFFECTS OF DIFFERENT CONCENTRATIONS OF PLASMA, SERUM 






Compact Colonies in Soft Agar Containing
Strain Plasma (%) Serum (%) Fibrinogen (%)
brino­
gen® 1.0 0.1 0.01 1.0 0.1 0.01 0.4 0.04 0.004
K, V, 5, 22, 
S 33, 96 + + + + - + + -t-
75, 79 + + + - + - - + + +
2, 28 - - - - - - - - - -
Slide and tube agglutinations.
Intermediate colony type; round, compact colony with slightly 
elongated base after 14 hours incubation at 37 C.
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Fig, 1.— A staphylococcal strain which is positive 
for coagulase and clumping factor after 14 hours incuba­
tion at 37 C in soft agar medium containing: (a) 1 per
cent plasma; (b) 5 per cent plasma; (c) 0.4 per cent fi­
brinogen; (d) 1 per cent plasma and 0.4 per cent fibrino­
gen; (e) 1 per cent plasma, 0.4 per cent fibrinogen, and 
0.3 per cent albumin; (f) basal medium only (control). 
Note compact colonies in all except control culture; co­
agulation zones in b, d and e.
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Fig. 2.— Growth of five different strains 
of staphylococci in plasma-fibrinogen-albumin 
soft agar: (a) positive for both coagulase and
clumping factor; (b) negative for both coagulase 
and clumping factor; (c) positive for coagulase 
only; (d) positive for clumping factor only; (e) 
mixed population with respect to coagulase and 
clumping factor.
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Less distinct coagulation zones were demonstrable in plasma soft 
agar containing higher concentrations (5 to 10 per cent) of pooled human 
plasma. The characteristic appearance, in plasma-fibrinogen-albumin soft 
agar, of strains which are positive for coagulase and negative for the 
clumping factor appeared to be extremely sensitive to minor changes in 
the agar concentration. Typically, however, this group of staphylococci 
form a "parachute" shaped colony in plasma-fibrinogen-albumin soft agar 
when the routinely used agar concentration of 0.15 per cent is accurately 
measured (Figure 3).
Table 3 summarized the typical results which correlate clumping 
factor and coagulase activity with the production, in soft agar media, 
of the compact colonies and coagulation zones, respectively. Staphylo­
cocci of the Sv strain produce compact colonies in plasma-fibrinogen- 
albumin soft agar which show evidence of slight elongation after 24 hours 
incubation. However, typical diffuse colonies were obtained when the 
organism was cultured in plasma-fibrinogen-albumin soft agar which con­
tained lowered concentrations of plasma (0.1 per cent) and fibrinogen 
(0.2 per cent), as well as 1 per cent plasma soft agar and 0.4 per cent 
fibrinogen soft agar. The parent (S) strain appears to be unstable; 
when subcultured, isolated compact colonies gave rise regularly to a 
mixture of predominantly compact colonies and a small, variable percent­
age of diffuse colonies in plasma soft agar and in fibrinogen soft agar. 
However, by removal of individual colonies from mixed soft agar cultures 
with a capillary pipette, it was possible to separate colonial types and 
to obtain pure substrains of diffuse or compact colonies in fibrinogen 
soft agar and in plasma soft agar.
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Fig. 3.— Typical appearance of colo­
nies of coagulase-positive and clumping 
factor-negative staphylococci in plasma- 
fibrinogen-albumin soft agar.
TABLE 3
COMPARISON OF DEMONSTRATION OF COAGULASE AND CLUMPING FACTOR ACTIVITY OF 
REPRESENTATIVE STAPHYLOCOCCAL STRAINS BY CONVENTIONAL 
METHODS AND BY THE SOFT AGAR TECHNIQUE
Strain
0)(0 <u
r—1 *H 4J 3 W DO 0 D CO O H
g e
■■ ....60 G CO G W 0) "rC ■H 0 'G 4J G CU4J-rC G O B Ü t-C r-C .H G CO CO 60 -Ur4 60O C
Basal Soft Agar Medium Contain
1% Plasma 5% Plasma 0.4% Fibrinogen 1% Plasma Plus 0.4% Fibrinogen Control
C^ CF^ C CF C CF C CF C CF
H, K, V, 5, 79, 96 + + t. + + + - + + + ..
22, S 33, 75 + + + +d + - + + + » »
2, 28, 64, S 33v - - - » - - o
Hv 2 + - - - - - - r-J « «
K 6, K 93 + - - - + - + - e>
K 93m + - + + + - + + + - +®
Sv + - - - + + - - + + - -
Hv 1, S 35s - + - + - + - +
S 35 - - - + - + - + -
18, 32, 95 + + Mixtures
- + + + - + + + - -
S + + Mixtures
- + + + - + + + - -
- - ± - -
Ln
^Results in 0.4 per cent fibrinogen and in rehydrated plasma.
C^, Coagulation zone around colonies.
^CF, Compact colonies.
'^ Narrow or indistinct coagulation zones.
^Unusually mucoid strain; in all soft agar media, forms large, round colonies which diffuse 
slightly after 24 hours incubation at 37 C.
^Positive in 0.4 per cent fibrinogen, but not in rehydrated plasma or lower dilutions of fibrinogen.
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Virulence of Staphylococci for Mice
Physiological Properties and Metabolic Products 
of Selected Staphylococcal Strains 
Results of tests for the ^  vitro properties commonly associated 
with Staphylococcus aureus are reported for the 13 strains selected for 
virulence studies (Table 4). Table 5 summarizes the results in relation 
to the four groups of staphylococci as divided according to their coagu­
lase and clumping factor properties.
Regardless of coagulase activity, the clumping factor-positive 
strains were pigmented, whereas clumping factor-negative strains included 
both pigmented and non-pigmented ones. All the coagulase-positive strains 
fermented mannitcl. Two of the 3 coagulase-negative, clumping factor- 
positive strains fermented mannitol, while both of the coagulase-negative, 
clumping factor-negative strains failed to do so. All of the 13 strains 
were catalase positive.
The hemolysin pattern of each of the 13 strains was determined by 
comparing the characteristic hemolysis produced on the human, rabbit and 
sheep blood agar plates following the recommendations of Elek and Levy 
(1950b, 1954). Delta hemolysin was produced by 12 of the 13 strains; it 
was the sole hemolysin in 9 strains, 4 of which were coagulase-positive, 
clumping factor-negative staphylococci. Only 2 of the 13 strains, Hv 2 
and S 35, produced alpha hemolysin, which produced a wide zone of com­
plete hemolysis on all of the blood agar media tested, as compared to 
narrow zone of complete hemolysis caused by delta hemolysin. Beta hemo­
lysin was produced by 3 of the 13 strains. It occurred as the sole hemo­
lysin in S 33 strain which produced a characteristic narrow zone of
TABLE 4
IN VITRO PROPERTIES OF STAPHYLOCOCCAL STRAINS SELECTED FOR VIRULENCE STUDIES
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S + + Y + + + + + + delta + + + + 29
H + + 0 + + + + + + delta + + 4- *- + + 52/80/81
V + + 0 + + + + + + delta + 4- - + + 52/80/81
NT*^S 33 + + C + + + - + - beta + + 4- - + +
Sv + tm Y + + + + + + delta + 4* 4* - + NT
K 6 + — W + + + + + + delta + + 4“ + + NT
K 93 + W + + + + + + delta + 4" - - - NT
K 93m + - W + + + + + + delta + 4- - + + NT
Hv 1 _ + 0 + + + + + + delta + + 4* + + 52/80/81
S 35 + C + + + + + alpha,
delta
4- + + NT
S 35s - + 0 + + + + + + delta + + 4- - + + 52/80/81
Hv 2 - - 0 + - + + + + alpha,
beta,
delta
- + - 4" - - NT
S 33v C + + + + + beta,
delta
+ 4- 4- + + NT




SUMMARY OF ^  VITRO PROPERTIES OF SELECTED STAPHYLOCOCCAL 















Catalase 4/4* 4/4 3/3 4/4
Pigment 4/4 1/4 3/3 2/2
Mannitol Fermentation 4/4 4/4 2/3 0/2
Hemolysin
alpha 0/4 0/4 1/3 1/3
beta 1/4 0/4 0/3 2/2
delta 3/4 4/4 3/3 2/2
Hemolysis of mouse 
blood 3/4 4/4 3/3 2/2
Staphylokinase 4/4 4/4 2/3 0/2
DNase 4/4 4/4 2/3 2/2
Phosphatase 4/4 4/4 2/3 1/2
Urease 0/4 0/4 1/3 2/2
Lipase 4/4 4/4 3/3 1/2
Egg-Yolk Reaction 3/4 3/4 3/3 1/2
Phage Typable 3/4 0/4 2/3 0/2
Ratio: Number of strains with positive reaction/total number of
strains tested in the particular coagulase-clumping factor group.
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partial hemolysis on human and sheep, but no hemolysis on rabbit blood 
agar plates. However, the hot-cold phenomenon of beta hemolysin was not 
operative in this case; there was no distinct change on reincubation of 
the sheep blood agar plate at 4 C following its incubation at 37 C. Hemo­
lysis on mouse blood agar plates was tested since the mouse was chosen 
as an experimental animal in the present virulence studies. Twelve of 
13 strains showed zones of complete hemolysis, whereas S 33 strain failed 
to cause any degree of hemolysis on mouse blood agar plates.
With the exception of the two coagulase-negative, clumping factor- 
negative strains (Hv 2 and S 33v) and the coagulase-negative, clumping 
factor-positive S 35 strain, staphylokinase was produced by all strains. 
Twelve strains, but not the S 35 strain, produced deoxyribonuclease 
(DNase) in varied amounts as estimated by the size of clearing zone which 
resulted on the DNA containing trypticase soy agar medium. Relatively 
high DNase activity was observed in the case of the S 33 strain; other­
wise, comparable amounts were produced by the other DNase positive 
strains. Only 2 of the 13 strains, S 35 and Hv 2, failed to liberate 
phosphatase. Urease was not produced by any of the coagulase-positive 
strains. Two strains (Hv 1 and S 35s) of the clumping factor-positive, 
coagulase-negative group did not produce urease, whereas S 35 strain and 
both of the coagulase and clumping factor-negative strains produced the 
enzyme. Lipase was produced by 12 of the 13 strains, but not by the Hv 2 
strain. In contrast, only two of the other strains (S and Sv) gave a 
negative egg-yolk reaction.
None of the four coagulase-positive, clumping factor-negative 
strains were phage-typable, nor were the two coagulase-negative, clumping
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factor-negative strains. Five of the 7 clumping factor-positive strains
were phage typable, and 4 of them had a 52/80/81 phage pattern.
Some of the variant strains, which were differentiated on the basis 
of morphological changes or by their coagulase and/or clumping activity, 
retained other properties in common with their parent strains. The Smith 
virulent (Sv) strains which was differentiated from its parent, the Smith 
(S) strain, by its loss of clumping factor activity, had similar prop­
erties as those of its parent except for being phage non-typable. A 
complete correlation existed between the properties of K 93m variant 
strain and its parent, the K 93 strain, from which it differed by its 
unusually mucoid character. There was complete correlation between the 
properties of Hv 1 variant strain and its parent H strain from which it
was differentiated by the loss of coagulase activity. There was no such
complete correlation between the H strain and its other variant, the Hv 2 
strain, which lost both coagulase and clumping factor activities. Com­
pared to its parent strain, the Hv 2 variant strain lost the ability to 
ferment mannitol, to produce staphylokinase, phosphatase, and lipase, 
to give a positive egg-yolk reaction, and to be lysed by phages. Further­
more, it differed from its parent H strain by positive urease activity 
and the production of alpha and beta hemolysins in addition to delta 
hemolysin. The S 33v variant strain, which lost coagulase and clumping 
factor activities, retained some, but not all, of the parent strain (S 33) 
properties (Table 4). In addition to stronger clumping factor activity 
and diffuse growth in broth cultures, the smooth variant S 35s was dif­
ferent from the S 35 strain in that it fermented mannitol, produced a 
deeper, orange pigment, and was positive for staphylokinase as well as
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for deoxyribonuclease. Furthermore, compared to its parent strain, the 
S 35s variant was phage typable, and produced no urease or alpha hemo­
lysin.
The 13 strains of staphylococci were susceptible to the majority 
of the chemotherapeutic agents tested (Table 6). Eight of the 17 agents 
were effective against all of the strains, whereas occasional resistant 
strains were encountered with the other agents. Four (H, Hv 1, S 35s, 
and S 33v) of the 13 strains were resistant to penicillin. Of all 
strains, the H strain showed the greatest resistance; it was resistant 
to 6 out of the 17 chemotherapeutic agents, and to the lower concentra­
tions of two other agents. All but two strains (S 35 and S 33v) were 
resistant to polymyxin B, and 9 of the 13 strains were resistant to 
triple sulfa and Gantricin. Some of the variant strains (Sv, K 93m and 
Hv 1) showed the same susceptibility to the chemotherapeutic agents 
tested as did their respective parent strains (S, K 93 and H). Other 
variants (S 33v, S 35s, and Hv 2), however, did not have the same sus­
ceptibilities as the parent strains.
Titration of coagulase in supernatants of centrifuged broth cul­
tures proved to be unsatisfactory because of the chance that viable staph­
ylococci might be present in the supernatants. The addition of 1:1000 
and 1:2000 merthiolate inactivated most, if not all, of coagulase activ­
ity. Coagulase activity of culture supernatants was lost after Seitz 
filtration. Titration of coagulase production was possible only when 
serum-culture sterile filtrates were used. Different degrees of coagu­
lase activity by the various strains were indicated by coagulase titra­
tion results (Table 7). The higher the coagulase titer, the less time
TABI.E 6
IN VITRO SUSCEPTIBILITY OF STAPHYLOCOCCI TO ANTIBIOTICS 
AND OTHER CHEMOTHERAPEUTIC AGENTS^
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S, susceptible; R, resistant.
TABLE 7






lase Serum-Culture Sterile Filtrate Dilution
Factor Titer
1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048
S + 1:1024 15 30 75 105 120 150 180 240 300 420 540
a
H + 1:64 45 90 120 240 300 480 1440 — — — —
V + 1:256 35 90 120 150 300 360 540 1440 1440 — —
S 33 + 1:128 20 45 90 120 150 300 480 600 —  — — —
Sv 1:256 15 60 90 120 180 210 300 360 1440
K 6 — 1:8 60 120 240 480 — — — — —  — — — —
K 93 — 1:8 60 120 240 480 — — — — —  — — —
K 93m - 1:8 90 420 600 1440 — — — — —  — —
Hv 1 + 0 — — — — — — — — — — —
S 35 + 0 — — — — — — — — '—  — — —
S 35s + 0 — — — — — — — — —  — — —
Hv 2 = 0
S 33v — 0 — — ~ — — — — — —  — — —
00w
*No coagulation after 24 hours incubation.
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was required for dilutions of the serum-culture sterile filtrates to 
clot a coagulation system of 1 per cent plasma-0.4 per cent fibrinogen- 
0.3 per cent albumin, the same system that was selected for use in the 
soft agar technique. Furthermore, the clots formed by strains of a high 
coagulase titer were regularly more firm than those formed by low coagu­
lase titer strains.
Loss of clumping factor activity by the Sv variant strain was ac­
companied by lowered coagulase titer (1:256) in comparison to 1:1024 
coagulase titer of its parent S strain. Strain K 93 and its variant 
strain (K 93m) as well as K 6 strain, all of which were coagulase-posi­
tive, clumping factor-negative, showed a relatively low coagulase titer 
of 1:8. The three other strains (H, S 33 and V) which were positive for 
clumping factor, had coagulase titers of 1:64; 1:128 and 1:256, respec­
tively.
Less variation was observed in the clumping factor activity of the 
various strains than in their coagulase production (Table 8). All but 
one of the clumping factor-positive strains were clumped in 0.02 per cent 
fibrinogen solution. The exceptional strain, S 35s, required a minimal 
fibrinogen concentration of 0.4 per cent in order to exhibit positive 
clumping factor activity. This strain also differed from all others by 
growing in the bottom of broth culture tubes with almost a clear super­
natant. An vivo smooth variant, S 35s, which produced diffuse growth 
in broth cultures, emerged in organs of mice infected with the S 35 
parent strain. The variant showed a stronger clumping factor activity; 
it clumped in 0.02 per cent fibrinogen. Equivocal results were obtained 
in the slide and tube agglutination test of the self agglutinating Hv 2
TABLE 8
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Highest dilution of fibrinogen in which clumping of the organisms occurred or the one which 




strain. However, it formed diffuse colonies in soft agar, and on this 
basis it lacked clumping factor activity.
When tested in soft agar media, all strains gave results comparable 
to those obtained in the conventional coagulase and clumping factor tests, 
with the exception of the autoagglutination property of Hv 2 strain men­
tioned above. The substitution of pooled mouse plasma for pooled human 
plasma as the substrate in coagulase and clumping factor yielded inter­
esting results. When tested by the slide agglutination and soft agar 
technique, all of the 13 strains gave the same clumping factor results 
in mouse plasma as they did in human plasma or in bovine fibrinogen.
Two of the 8 coagulase-positive strains (S and Sv) caused weak clotting 
of undiluted and diluted (1:2 and 1:4) mouse plasma in the conventional 
coagulase test. Strains S and Sv were also the only staphylococci tested 
which clotted a 0.4 per cent fibrinogen-1.5 per cent mouse plasma mix­
ture. Here, however, clotting was slow; both the S and Sv strains re­
quired four hours to give a positive coagulase test with mouse plasma 
as the source of the coagulase reacting factor as compared to 30 minutes 
clotting time when human plasma was used in the same way. In 0.4 per 
cent fibrinogen-1.5 per cent mouse plasma soft agar, narrow coagulation 
zones were formed around the colonies of the S and Sv strains. The 
addition of 0.3 per cent albumin to the system did not affect the appear­
ance of their coagulation zones (Table 9).
Results of the LD^q Determination
A comparison of the virulence of the selected strains was made by 
determining the IDgg of each strain, with the being defined as the
minimum number of staphylococcal units required to cause the death of
TABLE 9
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Coagulase as indicated by coagulation zones around colonies. 
^Clumping factor as indicated by compact colonies.
^Weak or doubtful results.
'^ Mucoid strain K 93m forms spherical colonies in all soft agar media.
88
50 per cent of the mice within 14 days after either intravenous or intra- 
peritoneal injection. Each challenge dose consisted of washed staphylo­
cocci suspended in 0.3 ml of phosphate-buffered saline. The experimental 
period of 14 days was found satisfactory since, as shown in preliminary 
trials, only rarely did death of an animal occur after this time.
No deaths occurred among mice which were injected intravenously 
or intraperitoneally with 0.3 ml amounts of (1) phosphate-buffered sa­
line, (2) sterile trypticase soy broth, (3) a sterile supernatant of a 
trypticase soy broth culture of each strain and (4) a heat killed (75 C 
for 45 minutes) cell buffered saline suspension of the highest challenge 
dose of each strain.
The averages of two determinations of each of the 13 strains
are recorded in Table 10. In this table, these strains are divided into 
four groups on the basis of their coagulase and clumping factor activi­
ties: Group I, positive for coagulase and clumping factor; Group II,
positive for coagulase and negative for clumping factor; Group III, 
coagulase-negative and clumping factor-positive; Group IV, negative for 
both coagulase and clumping factor.
Influence of the route of injection on LD^g. The results of LD50 
determinations of strains and the average LD^q for each group of staph­
ylococci (Table 10) indicate there is an interaction between their viru­
lence for mice and the route of injection. The coagulase-positive, 
clumping factor-positive staphylococci of Group I were somewhat more 
virulent for mice by the intravenous route than when they were injected 
intraperitoneally, with average LD50 values of 97.5 x 10^  and 212.8 x ic/, 
respectively. In contrast. Group II organisms of the coagulase-positive.
TABLE 10
ld.q of staphylococci inoculated intravenously





Group Average LD^q 
(XIO?)
Coagulase ClumpingFactor IV IP IV IP
S 1:1024 0.02 45.0 114.9
I H 1:64 0.02 64.2 279.4 97.5 212.8
V 1:256 0.02 27.4 31.9
S 33 1:128 0.02 254.8 425.0
Sv 1:256 0 4.0 1.1
II K 6 1:8 0 183.5 20.8 128.6 25.4
K 93 1:8 0 167.0 18.1
K 93m 1:8 0 160.1 61.5
Hv 1 0 0.02 97.2 358.0
III S 35 0 0.4 145.0 156.3 109.1 284.2
S 35s 0 0.02 85.1 284.2
IV Hv 2 0 0 940.0 315.0 1087.9 382.5
S 33v 0 0 1235.8 450.0
00
VO
The figures presented are arithmetical means of two LD^g determination values of each of the 
strains.
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dumping factor-negative strains were more virulent intraperitoneally 
(average LD^g, 25.4 x 10^ ) than by intravenous inoculation (LD q^ ,
128.6 X 10^ ). Indeed, when introduced by the intraperitoneal route.
Group II was the most virulent of all the groups; Group I was next most 
virulent and Group IV with an average intraperitoneal UD^q of 382.5 x 10^  
was least virulent of all. However, although the coagulase-negative, 
clumping factor-negative staphylococci of Group IV were least virulent 
by either route of injection, they were more virulent when injected intra- 
peritoneally than intravenously (average 1087.9 x 10^ ). These
observations, illustrated in Figure 4, were shown to be statistically 
significant when the over all mean values of strains within each of
the four groups, with the random elimination of S 35 strain of Group III, 
were compared by the Duncan multiple range test (Li, 1957). The analysis 
of variance (Snedecor, 1956) showed that the route by group interaction 
is statistically significant at the 1 per cent level (Table 11). The F 
value of the analysis signifies that such an interaction can be attri­
buted to chance less than 1 time in a 100.
With two exceptions, staphylococci of Group I appear to be more 
virulent intravenously than those of other groups. The LD^q of the first 
exceptional strain (S 33) was 254.8 x 10^ , which is higher than the mean 
LD5O value (45.5 x 10^ ) obtained for the other three strains of Group I, 
and than the LD^q value of all staphylococci in Groups II and III. The 
variation in LD^q value of S 33 may be due to its peculiar predilection 
for skeletal muscle rather than for the tissues of more vital organs 
such as the kidney, which was the usual site of lesions and persisting 




















Fig. 4.— Interaction of virulence (LD q^) of groups of 
staphylococci and the route of injection. Group I: coagu­
lase-positive, clumping factor-positive; Group II: coagu­
lase-positive only; Group III: clumping factor-positive only; 
Group IV: negative for both factors.
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TABLE 11
ANALYSIS OF VARIANCE OF THE INTERACTION AMONG 
STAPHYLOCOCCAL GROUPS BY VIRULENCE FOR 







Among groups 3 103,930.0 34,643.3
Between routes 1 1,354.7 1,354.7
Strain in group 8 104,395.7 13,049.5
Route by group interaction 3 32,125.4 10,708.5®
Replicates; strain by 
route in group 24 7,119.5 296,6
Strain by routes in 
group (error) 8 5,285.2 660.6
^ (318) ~ ‘5 - 16.21, P^O.Ol; P is the probability which
indicates that such an F value can be attributed to chance alone.
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intravenous LD50 value of 4.0 x 10^  was smaller than any of the other 
strains tested including the Group I organisms.
On the other hand, with one exception, staphylococci of Group II 
were more virulent by the intraperitoneal route than any organisms of 
the other groups. The exceptional strain (K 93m) had an UD50 value of 
61.5 X  10^ ; it was relatively less virulent than the V strain of Group 
I, which had an LD50 value of 31.9 x 10?. The most virulent strain of 
Group II by the intraperitoneal route was the Sv strain, which had an 
LD^q of 1.1 X ic/. K 93 and K 6 strains had LD50 values of 18.1 x 10^  
respectively, which were much lower than those obtained for staphylococci 
of the other groups (Table 10).
The coagulase-negative, clumping factor-positive staphylococci of 
Group III were, on the average, more virulent intravenously and intra- 
peritoneally than the coagulase-negative, clumping factor-negative strains 
of Group IV. Nevertheless, staphylococci of Group III were more virulent 
intravenously than when injected intraperitoneally, with mean IDgQ values 
of 109.1 X 10^  and 284.2 x 10^ , respectively. The LD^g values obtained 
by intravenous and intraperitoneal injection of strain S 35, however, 
were closely similar.
Results in Table 10 suggest that coagulase-positive staphylococci, 
.^e^ . , Groups I and II, were, on the average, more virulent intraperiton­
eally than the coagulase-negative strains of Groups III and IV. On the 
other hand, clumping factor-positive organisms of Groups I and III were 
more virulent intravenously than clumping factor-negative strains of 
Group IV and to a lesser extent than organisms of Group II.
When variant strains are compared with their respective parent
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strains, relative variation in their virulence may be noted (Table 10). 
The Sv strain was more virulent intravenously (LD q^ , 4.0 x 10^ ) and 
intraperitoneally (LD^g, 1.1 x 10?) than its parent, the S strain, which 
showed an of 45.0 x 10^  when injected intravenously and of 114.9 x
10^  when injected intraperitoneally. The Sv strain was originally dif­
ferentiated from its parent strain by loss of clumping factor activity. 
Further study also showed that it was phage non-typable and that it 
possessed a lower coagulase titer than its parent strain (Tables 4 and 
7).
The Hv 1 strain, which differed from its parent H strain, only by 
loss of coagulase activity, was relatively less virulent, than the parent 
strain both intravenously and intraperitoneally. In contrast, the second 
variant of the H strain, the Hv 2 strain, which lost both coagulase and 
clumping factor activities and differed from its parent in other aspects 
(Tables 4 and 6), was much less virulent intravenously and less so intra- 
peritoneally than its parent. The same situation was obtained when the 
S 33v variant strain, which is coagulase-negative, clumping factor-nega­
tive, was compared with its coagulase-positive, clumping factor-positive 
parent, the S 33 strain (Table 10).
The mucoid K 93m variant strain had an intravenous LDjq value of 
160.1 X 10^ , which was comparable to that of its parent K 93 strain 
(167.0 X 10^ ), whereas intraperitoneally, its ID50 (61.5 x lO?) was sig­
nificantly higher than that of the parent strain (18.1 x 10 )^.
A more complicated situation arises when the virulence of the S 33s 
variant strains is compared with that of its parent strain (S 35) from 
which it differed in several aspects besides possessing stronger clumping
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factor activity (Tables 4, 6 and 8). The variant S 35s strain was rela­
tively more virulent intravenously, but not intraperitoneally (Table 10).
Variation in virulence among the staphylococci tested is further 
evidenced by the death rate and the speed with which the different strains 
killed the mice (Table 12). Depending on the strain and the dose of 
staphylococci, most of the animal deaths occurred during the first week 
after inoculation.
As indicated in Table 12, relatively large numbers of organisms 
(8.0 X 10  ^or more) of the coagulase-negative, clumping factor-negative 
strains were required to cause death of the animals when injected intra­
venously or intraperitoneally. In contrast, the more virulent strains, 
which were characterized by lower LD50 values, killed all of the mice 
with lower challenge doses, , 4.0 x 10^  or less. Furthermore, de­
pending on the route of injection, virulent strains, e.g., Sv, V, K 93,
K 6 and S strains, killed a varied percentage of the animals with doses 
(2.5 X 10® or less) which were completely non-lethal in the case of the 
less virulent strains. Thus, while there was a gradual decrease in the 
death rate with decreased doses of the virulent strains, a sharp drop in 
the killing level was associated with the less virulent strains. This 
gradual decrease in the death rate of mice injected with the virulent 
strains was also accompanied by prolonged death time (Table 12).
Results of ID50 Determinations 
Determination of the ID50 was made on the basis of organisms re­
covered from infected mice which survived for 14 days after their injec­
tion intravenously or intraperitoneally with four-fold serially diluted 
doses of washed, phosphate-buffered saline suspended staphylococci.
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TABLE 12
DEATH RATE AM) TIME OF DEATH OF MICE INJECTED WITH STAPHYLOCOCCI 
BY THE INTRAVENOUS AND INTRAPERITONEAL ROUTES*









IV IP IV IP IV IP
S 1:1024 0.02 6/6^ 6/6? 6/6%» 6/614
H 1:64 0.02 6/6^ 6/6^^ 6/6^ 4/6^0 4/64» 1/6^»
V 1:256 0.02 6/6? 6/6^ 5/6%» 5/614
S 33 1:128 0.02 6/6^ 3/62» 1/65» 0/6
Sv 1:256 0 6/610 6/6^ 6/6^0 6/6^
K 6 1:8 0 6/64» 6/6^ 1/6^0 5/610
K 93 1:8 0 6/618 6/6^ 1/63» 6/618
K 93m 1:8 0 6/618 6/614 1/6=» 3/614
Hv 1 0 0.02 6/6^ 6/6^2 2/6*0 1/610
S 35 0 0.4 6/6? 6/614 3/6,14 2/6%»
S 35s 0 0.02 6/6% 6/610 3/618 1/61»
Hv 2 0 0 1/6* 6/6,14 0/6 3/610
S 33v 0 0 0/6 6/6,14 0/6 0/6
^Expressed ratio: number died/number injected in a given time.
Time of death (figure recorded at upper right of ratio) is expressed in 
hours if death occurred within 24 hours, or in days (D) if death 
occurred after 24 hours.
figures derived from averages of viable number of staphylococcal 
units injected.
^Where blanks occur, challenge dose was not within 15 per cent of 
the stated average number of viable staphylococcal units injected.
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TABLE 12— Continued
______ Average Number of Staphylococcal Units Injected"______
2.5x10® 6.2x10? 1.6x10? 4.0x10®
0/6














5/6*» 6/6? 3/68» 5/6
0/6 4/6^4 0/6 0/6





1/6^ ^ 0/6 0/6
0/6 0/6
2D i/6^ -3D 4/63D g/6 0/6
0/6 0/6 -----------
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The IDgQ dose can then be defined as that number of cocci which caused 
infection and persisted for a period of 14 days or longer in 50 per cent 
of intravenously or intraperitoneally injected mice. Arithmetical means 
of two ID50 determinations for each of the 13 staphylococcal strains are 
recorded in Table 13.
Twelve of the 13 staphylococcal strains were relatively more effec­
tive in establishing infection when injected intravenously than intra­
peritoneally. The one exception, strain S 33 of Group I, was more effec­
tive by the intraperitonea1 route. In other words, on the average, the 
four groups of staphylococci had relatively lower ID^g values when in­
jected intravenously than intraperitoneally (Table 13; Figure 5). How­
ever, the ID^o values of intravenously and intraperitoneally injected 
coagulase-positive staphylococci of Groups I and II were notably lower 
than those of similarly injected staphylococci of the coagulase-negative 
groups. When injected intraperitoneally, the ID50 values for Group I 
and Group II were comparable, whereas intravenously, the mean ID50 
(9.8 X 10^ ) of Group I was relatively higher than that of Group II 
(5.2 X  10?).
Among the coagulase-positive, clumping factor-positive staphylo­
cocci of Group I, the S 33 strain was the least effective in establish­
ing infection regardless of the route of injection. Comparable IDgg 
results were obtained with the other (S, H and V) strains of Group I 
when they were injected intraperitoneally, but when introduced intra­
venously the V strain was the most effective of these three strains in 
establishing infection (ID^ Q, 0.6 x 10^ ) whereas the H strain was the 
least effective (ID^ g, 6.0 x 10?).
TABLE 13
ID50 OF STAPHYLOCOCCI INOCULATED INTRAVENOUSLY 




Group Average ID^q 
(XIO?)
Coagulase ClumpingFactor IV IP IV IP
S 1:1024 0.02 1.3 13.6
I H 1:64 0.02 6.0 15.8 9.8 16.5
V 1:256 0.02 0.6 13.3
S 33 1; 128 0.02 31.3 23.2
Sv 1:256 0 0.3 0.7
II K 6 1:8 0 7.5 14.0 5.2 18.0
K 93 1:8 0 7.0 10.4
K 93m 1:8 0 5.9 47.0
Hv 1 0 0.02 4.4 40.8
III S 35 0 0.4 114.7 156.3 40.7 73.5
S 35s 0 0.02 2.9 23.5
IV Hv 2 0 0 32.0 55.0 44.2 252.5


































Fig. 5.— Interaction of infectivity (ID^q) of staphylo­
coccal groups and the routes of injection. Group I: coagu­
lase-positive, clumping factor-positive; Group II: coagulase-
positive only; Group III: clumping factor-positive only;
Group IV: negative for both factors.
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Of the 13 strains, the strain with highest infectivity, whether by 
the intravenous or intraperitonea1 route, was the Sv strain of Group II. 
Its ID^Q values were 0.3 x 10^  intravenously and 0.7 x 10^  intraperiton­
eally. The ID5Q values obtained for K 6 and K 93 strains of Group II 
when injected intravenously as well as intraperitoneally were similar.
The K  6 strain gave ID^g values of 7.5 x 10^ and 14.0 x 10^ when injected 
intravenously and intraperitoneally, respectively, as compared to an 
intravenous IDgg of 7.0 x 10^ and an intraperitonea1 ID^g of 10.4 x 10^ 
for the K 93 strain. The mucoid variant, K 93m, was notably more suc­
cessful in establishing infection intravenously (ID^ q, 5.9 x  10?) than 
intraperitoneally (ID^g, 47.0 x lO?).
The coagulase-negative, clumping factor-positive staphylococci of 
Group III were more infective than Group IV when injected intraperiton­
eally, but much less so when injected intravenously. Group III included 
the S 35 strain which was weakly infectious by either route as compared 
to the two organisms of the same group. The smooth variant (S 35s 
strain) was more infectious than its rough parent, the S 35 strain, when 
injected intravenously as well as intraperitoneally. Its intravenous 
and intraperitoneal ID^g values of 2.9 x 10^  and 23.5 x 10^ , respectively, 
were much lower than those of the parent S 35 strain (Table 13).
Course of Infection and Persistance 
of Staphylococci in Mice
The course of infection in mice during the 14 day experimental 
period was followed by post-mortem examination for gross and microscopic 
lesions, as well as by determination of viable organisms in the organs 
and exudates, of all mice at the time of their deaths or sacrifice.
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Mice injected with sublethal doses of the 13 strains of staphylococci 
were examined for persistance of the infecting organisms at two week 
intervals up to six weeks and, in some instances, eight weeks after in­
jection.
Course of infection and persistance of staphylococci following 
intravenous inoculation. All strains, regardless of their coagulase or 
clumping factor character, dessiminated and were abundant in the blood, 
lungs, liver, spleen and kidneys of the mice within two hours after intra­
venous injection. As would be expected this was most pronounced with 
high challenging doses. High numbers of viable staphylococci were present 
in the blood, spleen, liver and lungs at 2 to 3 days post-infection time. 
Thereafter, a steady decline in the bacterial numbers in these organs 
occurred and usually ended with complete disappearance of staphylococci 
by the 10th to 14th day. In rare instances, a small number of organisms 
persisted for more than two weeks. Such a persistance of the organisms 
in the lungs, liver, or spleen generally was accompanied by abscess 
formation in the case of the more virulent strains such as the Sv, V and 
S.
A different course of events took place when infection was estab­
lished in the kidneys, a common site for multiplication and persistance 
of the staphylococci (Table 14). After an initial low level in the 
numbers of staphylococci in the kidneys, which appeared to last for a 
few hours, a steady increase in the bacterial population began. The 
maximal count of viable staphylococci in the kidneys was usually reached 
by the 3rd to 5th day and was followed by a leveling off of the numbers 
recovered up to the 14th post-infection day. Subsequently, as indicated
TABLE 14
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S + + 1.3 4 (1) (1) (1) (1) ( 2 ) 4 ( 2 ) 3 (1)
I H + + 6 .0 4 3 2
V + + 0 . 6 4 (1) (1) (1) (1) (3) 4 ( 2 ) 3 (1) (1) ( 2 )
S 33 + + 31.3 (1) (1) 3 (1) 3 2
Sv + - 0.3 4 (1) (1) (1) (1) (3) 4 (3) 3 (1) ( 2 )
II K 6 + - 7.5 3 ( 2 ) 3 ( 2 ) 2 (1)
K 93 + - 7.0 3 (1) ( 2 ) 3 ( 2 ) 2 (1) (1)
K 93m + - 5.9 3 (1) 2 2
Hv 1 - + 4.4 4 (1) 3 2 (1) (1)
III S 35 - + 114.7 (1)
S 35s - + 2.9 4 (1) (2) 3 (2) (1)
IV Hv 2 - - 32.0 2 (1) 2
S 33v 56.3 2 (1)
ow
The relative number of organisms is graded from 1 to 4, with 1 indicating a few and 4 an 
abundant number of organisms recovered. Parentheses indicate organisms were recovered only 
occasionally.
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in Table 14, there was a gradual decline in the number of viable organ­
isms of the more virulent strains (Sv, S and V strains) for as long as 
the mice were examined, whereas the organisms of the less virulent or 
avirulent strains (S 35, Hv 2 and S 33v) had disappeared from the kidneys 
by the fourth week.
When examined one week after challenge, the gross appearance of 
the infected kidneys was apt to differ with the strain of staphylococcus 
injected (Figure 6). This was most evident when the infecting staphylo­
coccus was clumping factor-positive or when it was the clumping factor- 
negative, coagulase-positive Sv strain. However, formation of multiple 
kidney abscesses (Figure 6a,b) was characteristic of the clumping factor- 
positive staphylococci of Groups I and III (Table 14). Miscroscopic 
examination* of such kidneys revealed focal septic infarctions with in­
filtration of polymorphonuclear leukocytes and cocci throughout the 
kidney. Many of the glomeruli appeared acutely inflamed. Septic in­
farction was initiated and was most extensive in the cortex, but the 
medulla was also involved in cases of severely infected kidneys. Necro­
sis of the adjacent adrenal glands was not an unusual observation.
In contrast to the pathology produced by the clumping factor-posi­
tive staphylococci, grossly visible subcapsular abscesses were rarely 
observed in the kidneys of mice which died within 14 days after injection 
of clumping factor-negative strains (Group II and Group IV). Instead, 
such kidneys were usually partially or entirely pale in appearance 
(Figure 6d). When occasional, visible kidney abscesses did develop
Histopathological examinations were made by members of the Depart­
ment of Pathology, University of Oklahoma Medical Center.
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Fig. 6.— Variation in gross appearance of kidneys from 
mice infected with staphylococci; a and b are characteristic 
of clumping factor-positive staphylococci infected kidneys, 
whereas c and d are typical of infections of prolonged and 
short duration, respectively, with clumping factor-negative 
staphylococci; e is a normal mouse kidney.
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(Figure 6c), it was late in the course of infection, about 4 to 6 weeks 
after inoculation of the animals. The histopathological picture of these 
kidneys revealed pyelitis with encapsulated abscesses in the region of 
the papillae and pus in the pelvis of the kidney.
The degree of reaction in the kidneys then depended on the staphylo­
coccal strain, the size of the challenge dose and the time of death or 
sacrifice of the animal. It was most extensive with the more virulent 
strains and, in general, reached a peak at 7 to 10 days after injection. 
Such kidneys were necrotic when examined 6 or 8 weeks post-infection. 
Animals with extensive kidney damage were usually obviously ill by the 
6th to 8th post-infection week.
Microscopic infection of kidneys, without gross pathological changes 
other than enlargement,.was évident .in mice infected with large doses of 
the less virulent strains (S 35, Hv 2 and S 33v) and in mice infected 
with lower doses of more virulent strains. In these animals dilation of 
the tubules of these kidneys was the usual microscopic impression. How­
ever, such kidneys were usually sterile by the fourth post-infection week.
Although the kidney was the most common site of infection, other 
organs were occasionally involved. Abscesses were frequently observed 
in the skeletal muscles and also in the heart muscle. Liver, spleen 
and brain abscesses were seen much less frequently and were usually 
characteristic of strains which were relatively virulent by the intra­
venous route. Enlargement of the spleen with or without abscess forma­
tion was common. Persistance of infection for 14 days in organs other 
than the kidneys, without grossly visible lesions, usually followed intra­
venous challenged with large doses of the more virulent staphylococci.
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The blood stream of the mice was usually free of the organisms by the 
second week after injection, but reappearance of a small number of or­
ganisms in the blood was not infrequent six weeks after infection with 
most of the clumping factor-positive staphylococci (Table 14).
Strain S 33 showed a remarkable predilection for skeletal muscle. 
Formation of abscesses in the muscles of thighs and/or shoulders, rather 
than in the kidneys, was the usual consequence of infection (Table 14). 
Miscroscopic examination revealed bone, as well as muscle, involvement 
and gave an impression of osteomyelitis. Only when high doses of strain 
S 33 were injected intravenously were organisms recovered from the 
kidneys and then no gross pathology was observed.
Course of infection and persistance of staphylococci following 
intraperitoneal inoculation. Large challenge doses of intraperitoneally 
injected virulent staphylococci, in particular those of Group II, killed 
mice rapidly, within 2 to 5 hours. Similar and large inocule of the 
less virulent strains failed to produce any more than transitory signs 
of illness for the first few hours. Early death of the animals was 
abrupt and was preceded by marked respiratory distress and convulsions. 
On post-mortem examination, the peritoneal fluid, blood, liver and 
spleen of such animals were heavily infected with the organisms, whereas 
fewer organisms were recovered from the lungs and kidneys.
The events of the first week after intraperitoneal injection were, 
in general, similar to those observed following the intravenous inocula­
tion. However, fewer organisms were present in the organs of mice in­
jected intraperitoneally than in those injected intravenously with 
comparable doses of clumping factor-positive staphylococci. On the
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other hand, the clumping factor-negative staphylococci, in particular 
strains of Group II, did not show such a difference.
Recovery of relatively small numbers of staphylococci from the 
kidneys was a common characteristic of all of the 13 staphylococcal 
strains throughout the course of intraperitoneal infection as compared 
to the high numbers recovered after their intravenous inoculation. 
Persistance of infection with abscess formation in the peritoneal wall 
and viscera was also observed following the intraperitoneal injection 
of clumping factor-positive staphylococci (Groups I and III) and of 
the Sv strain of Group II, but much less frequently than with the other, 
clumping factor-negative, organisms.
After intraperitoneal injection persisting infection beyond the 
experimental period of 14 days was localized mainly in the peritoneal 
and/or in the kidneys (Table 15). The extent of persisting infection 
varied with the staphylococcus injected, its coagulase and clumping 
characters and, as expected, with the size of the challenging dose. No 
organisms, however, were recovered from the peritoneal fluid after 10 
days, but abscess formation in the peritoneal wall, spleen and liver 
ligaments as well as intestinal mesentery were common. Enlargement of 
the spleen was a striking and common observation when virulent strains 
were injected intraperitoneally. Miscroscopic examination of such 
spleens revealed hyperplasia of germinal centers and the conspicuous 
presence of giant mononuclear leukocytes. On the other hand, following 
intraperitoneal challenge there was much less kidney damage than when 
comparable doses of the same strains of staphylococci were injected 
intravenously.
TABLE 15
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S + + 13.6 3 (1) 4 (1) 3 4 2 4
I H + + 15.8 3 4 3 4 2 3
V + + 13.3 3 (1) 4 (1) (1) 3 4 3 (1) 3
S 33 + + 23.2 (1) 4 (1) 3 3
Sv + - 0.7 3 3 (1) (1) 3 3 3 2
II K 6 + - 14.0 3 1 (2) 1 1
K 93 + - 10.4 3 2 2
K 93m + - 47.0 3 (1) (2) (1) (1) (1) 1 2 (2) 1 (2)
Hv 1 + 40.8 3 3 2 2 1 1
III S 35 - + 156.3
S 35s - + 23.5 3 3 2 3 1 1
IV Hv 2 - 55.3 2
S 33v — 450.0 2
o
vX)
^The relative number of organisms Is graded from 1 to 4, with 1 Indicating a few and 4 an 
abundant number of organisms recovered. Parentheses Indicate organisms were recovered only 
occasionally.
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Moderate numbers of the coagulase-negative, clumping factor- 
negative organisms of Gro.p IV persisted in the kidneys for two weeks 
but were almost completely eliminated by the fourth post-infection 
week. Likewise, organisms of the S 35 strain of Group III were com­
pletely eliminated two weeks after their intraperitoneal injection.
No viable organisms were ever recovered from purulent material of ab­
scesses produced by the S 35 strain. Organisms of other strains of 
Group III declined gradually in number from the kidneys and peritoneal 
abscesses, but they persisted in lowered numbers for six weeks post­
infection. A gradual decrease in the numbers of coagulase-positive 
staphylococci (Groups I and II) in abscesses was also noted, but these 
organisms persisted in all types of kidney lesions for 6 to 8 weeks.
In vivo Stability of Staphylococci
Staphylococci recovered from infected mice were cpmpared with 
the organisms injected in order to'evaluate the in vivo stability or 
variation of strains, particularly with respect to coagulase and clump­
ing factor activity.
A morphologically distinct mucoid variant, the K 93m strain des­
cribed above, was recovered from the kidneys of several mice five weeks 
after their intravenous injection with the K 93 strain. The mucoid 
character of this variant was stable ^  vitro after more than 30 culture 
passages or as long as examined. Likewise, it appeared to be stable 
in vivo since organisms of the same general character were isolated from 
mice in the eighth week of infection. In a few instances, however, the 
isolates were even more mucoid and, unlike the parent K 93 and the orig­
inally isolated K 93m strain, some were weakly pigmented.
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A stable, smooth variant, the S 35s strain, was recovered from 
kidneys of mice which were sacrificed two weeks after intravenous in­
jection with the rough S 35 parent strain. The smooth variant was 
easily detected in fibrinogen soft agar cultures by its large colony 
size as compared to that of the parent strain. It had a high clumping 
factor titer than the original strain (Table 7) and it also differed in 
certain other characteristics including phage typability (Tables 4 and 6).
Two other variants, Sv and Hv 1, were encountered regularly, al­
though in varied proportions, in soft agar cultures of staphylococci 
which were recovered from mice infected with the S and H strains, respec­
tively. Both of these variants also occurred as a result of in vitro 
cultivation of their respective parent strains.
The Sv strain used in the present studies was originally isolated 
from the Smith (S) strain by Hunt and Moses (1958) who noted that it 
differed from the parent (S) by formation of diffuse colonies in plasma 
soft agar. These workers reported that the Smith "mouse virulent" strain 
(Sv) emerged in high proportion from mice inoculated intraperitoneally 
with the Smith "mouse avirulent" strain. In the present study, the Sv 
variant proved to be completely stable in vivo and in vitro. When mice 
were infected with the S strain, however, the Sv variant emerged in vivo 
as a small minority (5 to 10 per cent) of the staphylococcal populations 
recovered from the infected mice.
The Hv 1 variant of the H strain was distinguished by its loss of 
coagulase activity. It was recovered in various proportions (5 to 20 
per cent) from infected organs of all mice injected with the H strain.
The Hv 1 variant appeared to retain all of the parental properties other
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than coagulase activity and it was stable vivo as well as iji vitro 
for as long as examined.
Dwarf colonies, similar to those described by Wise (1956), were 
commonly observed in cultures made from injected mice, particularly 
from mice sacrificed two weeks after injection. These dwarf colonies, 
however, always reverted to regular colony size by the second or third 
in vitro subculture.
Except for the variations noted above, the staphylococcal strains 




Demonstration of Staphylococcal Clumping Factor 
and Coagulase in Soft Agar 
The soft agar method proved to be effective for demonstrating both 
the clumping factor and coagulase activities. This technique was found 
to have certain advantages over conventional methods. It overcomes the. 
problem presented in slide and tube agglutination tests by rough strains. 
It may reveal the heterogeneity of a strain with regard to coagulase and 
clumping factor as expressed by coagulation zones and colonial compact­
ness, respectively. Thus, the discovery in pure or mixed populations of 
rare strains which possess either coagulase or clumping factor, but not 
both of these characters, is readily accomplished by this method. There 
was no evidence that the coagulation zones which form around the colonies 
of coagulase-positive staphylococci in plasma-fibrinogen-albumin soft 
agar failed to develop or disappeared as the result of staphylokinase 
activity. The soft agar method also proved valuable for simultaneous 
quantitative estimation of staphylococci recovered from organs and exu­
dates of infected mice and the detection of their coagulase and clumping 
factor activities without any intermediate cultivation which might affect 
the m  vivo character of the organisms. Previous attempts have been 
made to modify the conventional tests for coagulase and the ability of
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staphylococci to agglutinate in plasma or fibrinogen in order to obviate 
irregular results (Chapman et al., 1941; Miale and Faye, 1948; Elek,
1959; Jenkins and Metzger, 1959). At the research level at least, the 
soft agar method appears to be more accurate and consistent than the 
previously described methods for detection of these properties. In addi­
tion, the soft agar technique lends itself to titration of the clumping 
factor activity.
Most coagulase-positive staphylococci produce spherical, compact 
colonies in 0.04 per cent fibrinogen soft agar, in 0.1 per cent plasma 
soft agar and in 1 per cent serum soft agar medium. Jensen (1958) re­
ported on the regular occurrence in human serum of an antibody which re­
acts with a cellular component of staphylococci belonging to serological 
type I of Cowan. Antibody action cannot be excluded as a contributing 
factor in the colony compacting mechanism in plasma soft agar or in serum 
soft agar, but it is not necessarily the sole factor since all strains 
which are positive for clumping factor also form compact colonies in bo­
vine fibrinogen soft agar. Various investigators (McCarty, 1946; Pike, 
1946; Pittman and Davis, 1950; Lankford et £l., 1955) have used a soft 
agar technique successfully in studies of variation. The present soft 
agar method could undoubtedly be adapted to study of other staphylococcal 
variations, particularly antigenic variations, as well as to variations 
in the coagulase and clumping factor activities of staphylococci.
The presence of serum or plasma, which contain coagulase-reacting 
factor, is essential for the coagulation zone phenomenon in soft agar as 
it is for the plasma clotting reaction in the routine coagulase test. 
Finkelstein and Sulkin (1958) noted that halos were visible occasionally
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around compact staphylococcal colonies in soft agar medium which con­
tained high concentrations of serum. The combination of 0.3 per cent 
albumin, 1 per cent plasma, and 0.4 per cent fibrinogen in soft agar pro­
vides a medium in which even weak producers of coagulase form remarkably 
clear coagulation zones. In basal soft agar any concentration of plasma 
or serum which is adequate for distinct coagulation zone formation is 
capable of compacting colonies of strains which have the clumping factor. 
Less distinct coagulation zones were formed by some, but not all, of the 
coagulase-positive staphylococci tested in 5 to 10 per cent human plasma. 
The absence of distinct coagulation zones in such high concentrations of 
plasma in soft agar cultures may be due to the presence of anticoagulase 
antibodies or, possibly, to digestion of the fibrin by staphylokinase 
although, as mentioned above, there was no evidence for the latter in 1 
per cent plasma containing soft agar cultures.
Narrow and indistinct coagulation zones were formed by two high 
coagulase producing strains (S and Sv) when 1.5 per cent mouse plasma was 
substituted for 1 per cent human plasma as a source of coagulase reacting 
factor in plasma-fibrinogen soft agar. A 0.4 per cent fibrinogen-1.5 per 
cent mouse plasma (or serum) coagulation system was slowly but firmly 
clotted by the same two strains and no others when examined by the con­
ventional plasma clotting test. Unusual clotting of mouse plasma by 
staphylococci was reported by Gorrill (1951). Tager and Hales (1948a) 
indicated that coagulase-reacting factor (CRF) is present in high titers 
in human and rabbit plasmas and that there is little variation in the 
amount of CRF in different samples of human plasma (Tager and Hales, 
1948c). Plasmas of other animal species, including the mouse, were less
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effective in activating coagulase when used in the unmodified state due 
to low CRF titer, but additional CRF was released by acid precipitation 
of these plasmas (Tager and Hales, 1948a).
The formation of compact colonies by coagulase-positive staphylo­
cocci in serum- or plasma-containing soft agar has been attributed to the 
action of specific antibody or to factor(s) resembling antibody in normal 
rabbit and human plasma and sera (Finkelstein and Sulkin, 1958; Hunt and 
Moses, 1958). If the findings which contribute to this interpretation 
are re-examined with respect to the effect of staphylococcal clumping 
factor on colonial form in fibrinogen soft agar, it appears that anti­
body action in the usual sense is not the only possible explanation. Un­
doubtedly, specific antibody is operating at serum dilution of 1:10,000 
and more, but the compact "tailed" colonies which develop in soft agar 
containing 1:1000 rabbit antiserum (Finkelstein and Sulkin, 1958) appear 
to be the same as the intermediate colony type, compact with elongated 
base, which were observed in the 0.1 per cent normal serum soft agar and 
the 0.004 per cent fibrinogen soft agar cultures herein described. High­
er concentrations of serum, plasma, or fibrinogen in soft agar media re­
sult in the formation of spherical, compact colonies by strains of staph­
ylococci which are positive for clumping factor regardless of their co­
agulase activity or probably, serological type.
In the demonstration of coagulase and clumping factor in plasma 
containing soft agar, a fibrinogen soft agar culture is a necessary con­
trol. In certain strains, such as the Sv strain (Table 3), colonial 
diffusion is retarded in plasma-fibrinogen-albumin soft agar, but not in 
fibrinogen soft agar or plasma soft agar in which no clotting occurs.
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The fact that the Sv strain is a stronger coagulase producer than the 
other clumping factor-negative strains tested (Table 7) may account for 
inhibition of elongation of its colonies. Only after 24 hours incubation 
that slight elongation of the Sv colonies is observed. Nevertheless, a 
typical picture (Figure 4) of the Sv strain mé,y still be seen in 0.1 per 
cent plasma-0.04 per cent fibrinogen-0.3 per cent albumin soft agar,
.^e^ . , with soft agar which contains only 1/10 the usually employed con­
centrations of plasma and fibrinogen.
In the case of the unusually mucoid K 93m strain (Table 3), an 
additional basal soft agar medium was required as a control in the soft 
agar method. This strain formed large, spherical colonies in all soft 
agar media, including the basal soft agar, during the first 24 hours in­
cubation and only slight diffusion of the colonies occurred after that 
time. The delay in colonial elongation appears to be due to the elabora­
tion of a substance, probably a mucopolysaccharide, which is extruded in 
the form of a slime layer around the cocci. Such a layer, not discrete 
enough to call a true capsule, was seen in preparations stained by special 
capsule staining methods. Colonies of this mucoid strain were extraordi­
narily large in soft agar as well as on blood agar plates where their 
viscid consistency was remarkable. The isolation of mucoid staphylococcal 
strains was reported by several workers (Elek, 1959), including Reimann
(1957) and Wiley (1959).
The use of the soft agar technique is efficient in the discovery 
of rare staphylococcal strains or variants in mixed populations which 
possess coagulase or clumping factor but not both of these properties.
Hunt and Moses (1958) reported isolation of an exceptionally mouse
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virulent strain, the Smith "mouse virulent" (Sv) strain, which forms 
diffuse colonies in plasma soft agar, as compared to its relatively 
avirulent parent strain, the Smith (S) strain, which forms compact colo­
nies in plasma soft agar. The present study shows that other rare co­
agulase-positive staphylococci which also form elongated, diffuse colo­
nies in fibrinogen soft agar (Figure 4) and fail to agglutinate in 
fibrinogen are also more virulent for mice when inoculated intraperiton­
eally than any of the coagulase-positive, compact colony forming staph­
ylococci tested.
Comparative Virulence of Staphylococci for Mice 
It is generally believed that mice are more susceptible to bacterial 
infection by the intraperitoneal route than by the intravenous route of 
injection. Dutton (1955), in his comparative study of the influence of 
the route of injection on infections in mice caused by a variety of micro­
organisms concluded that a lower lethality was obtained when most organ­
isms, including staphylococci, were injected intravenously rather than 
intraperitoneally. The author suggested that this difference in the sus­
ceptibility of mice to the two routes of injection may be a phenomenon of 
non-specific immunity. Controversial statements have appeared in the lit­
erature as to the influence of route of injection on the susceptibility 
of mice to experimental staphylococcal infection (Elek, 1959). While 
some investigators have used the intravenous route (Gorrill, 1951, 1958; 
McCune et al., 1956; Smith, 1956; Smith and Dubos, 1956a; Gray et al., 
1957; Smith et al., 1957; Sellers and Le Maistre, 1960), others have 
inoculated mice with staphylococci by the intraperitoneal route (Christie 
et £l., 1946; Fisher and Thompson, 1956; Hunt and Moses, 1958; Fisher,
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1959). The mouse is, at best, relatively resistant to infection with 
staphylococci and large inocula of these organisms are required to kill 
mice or even to establish a staphylococcal infection, regardless of the 
route of injection.
In the present investigation, a definite interaction between the 
virulence of staphylococci and the route of injection is indicated.
This relationship, however, depended on the nature of the staphylococcus 
injected with respect to its coagulase and clumping factor activities. 
Among the limited number of staphylococci tested (13 strains), clumping 
factor-positive staphylococci (Groups I and III) were found to be more 
virulent and more infective for mice when injected intravenously than by 
the intraperitonea1 route, regardless of coagulase activity (Tables 10 
and 11). The coagulase-positive, clumping factor-positive staphylococci 
of Group I were the most virulent of all when injected by the intravenous 
route.
On the other hand, the clumping factor-negative staphylococci of 
Groups II and IV were more virulent for mice when injected intraperiton­
ea lly than when the same organisms were introduced intravenously regard­
less of their coagulase activity (Table 10). Furthermore, the coagulase- 
positive, clumping factor-negative staphylococci of Group II were more 
virulent by the intraperitonea1 route than any of the other staphylococci 
tested (Table 10; Figure 4).
With two exceptions (Johanovsky, 1957b; Hunt and Ifoses, 1958) pre­
vious staphylococcal virulence studies have differentiated between coagu­
lase-positive and coagulase-negative staphylococci without regard to 
clumping factor activity. Several investigators have indicated the
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existence of rare staphylococcal strains which possess coagulase or clump­
ing factor activity exclusively (Cadness-Graves £t al., 1943; Needham 
et al. , 1945; Williams and Harper, 1946; Duthie, 1954a, 1955; Klemperer 
and Haughton, 1957; Ness, 1957; Jenkins and Metzger, 1959). However, 
such strains were generally considered to be of doubtful pathogenicity 
(Duthie, 1955).
Johanovsky (1957b) was the only one to associate the clumping factor 
with the virulence of staphylococci. He suggested that the clumping fac­
tor rather than coagulase may contribute to the survival of staphylococci 
inside phagocytes. Although he used staphylococcal strains which were 
clumping factor-positive and others which were clumping factor-negative, 
the coagulase activity of both groups was not clearly indicated. Since 
coagulase-negative, clumping factor-positive strains are rarely encounter­
ed, it is suspected, from the number of strains tested, that he most 
probably utilized strains that were positive for coagulase and clumping 
factor and others which were negative for both factors, although from 
his report this is not clear.
Hunt and Moses (1958) reported on the unusual mouse virulence of a 
variant of the Smith strain of aureus by the intraperitoneal route.
The Smith parent strain had previously been recognized as being exception­
ally virulent for intravenously injected mice (Smith and Dubos, 1956a;
Gray et al., 1957). The Smith variant strain, recognized by its diffuse 
colonial growth in plasma soft agar, was reported to be antigenically 
distinct from the parent strain. It was found to have an LD^Q value of 
4 X 10^ , whereas 1 x 10^ organisms of other coagulase-positive staphylo­
cocci, including the Smith strain, failed to kill mice consistently.
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A relatively higher intraperitoneal ID^g value (1.1 x 10^ ) of the 
Smith variant strain was obtained in the present investigation. However, 
this difference may very well be explained on the basis of experimental 
variation. Results are influenced by the age and inherent susceptibility 
of the strain of the mice. The viable count of staphylococci is subject 
to considerable variation following minor changes in procedure. Further­
more, the volume of the challenge dose was found to influence the estimate 
of the virulence of staphylococci for mice. A 0.5 ml dose (used by Hunt 
and Moses, 1958) killed more mice than a 0.3 ml dose (used in the present 
study) containing the same number of viable cocci.
The virulence of staphylococci for mice appears to be greatly en­
hanced when the organisms are suspended in hog gastric mucin before their 
intraperitoneal inoculation (Anderson and Gag, 1939; Schneierson and 
Amsterdam, 1956). However, the effect of mucin is actually one which 
decreases the defense mechanisms of the host (Lambert and Richley, 1952; 
Wilson and Miles, 1955). By the use of mucin. Hunt and Moses (1958) re­
ported exaggerated differences between the LD^q values of the "Smith 
virulent" variant and the "Smith mouse avirulent" parent strain. Thus, 
the LD50 of the Sv strain was lowered to about 580 cells per mouse, 
whereas that of other coagulase-positive staphylococci, including the 
parent Smith strain, was at the level of 1 x 10^  viable cells.
Between 1956 and 1957 two coagulase-positive, clumping factor-
negative strains (K 6 and K 93) as well as two coagulase-negative,
clumping factor-positive strains (Hv 1 and S 35) were recognized in 
this laboratory. During the present study, other investigators* have
*Personal communications from Dr. George A. Hunt, Bristol Labora­
tories, Inc. and Dr. Myron W. Fisher, Parke-Davis and Company.
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examined the K 6 and K 93 strains for mouse virulence by intraperitoneal 
injection of mucin suspensions of the organisms. From their results it 
is evident that, first, these strains, like the Smith "mouse virulent" 
variant, are unusually virulent for mice by the intraperitoneal route, 
and, second, compared to the results presented here, mucin greatly exag­
gerates their virulence,
Fisher and Thompson (1956) found that a toxic substance, which was 
heat labile and inseparable from actively growing bacteria, was respons­
ible for the rapid killing of mice when they were inoculated intraperiton- 
eally with certain strains of staphylococci. The same workers indicated 
that formation and absorption of a highly toxic substance in the periton­
eal cavity, rather than dessimination of the organisms into the organs 
or blood stream, was responsible for the death of the animals. Hunt and 
Moses (1958) noted that the Smith "mouse virulent" variant only grew 
rapidly within the peritoneal leukocytes, whereas the Smith "mouse aviru­
lent" parent strain and other coagulase-positive staphylococci tested did 
not, although they remained viable for many hours. Depending upon the 
challenge dose. Hunt and Moses observed a marked and consistent prolifera­
tion of the Smith variant strain within the leukocytes for 8 to 12 hours. 
At the end of this period, there was an abrupt appearance of overwhelming 
numbers of extracellular staphylococci and the mice died within the next 
20 to 40 minutes. The authors suggested that a leucocidic activity, due 
to high concentrations of delta hemolysin, may have caused the abrupt 
death of the animals.
It is reasonable to assume that clumping of the staphylococci may 
permit the phagocytes to engulf a greater number of organisms than would
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be the case with staphylococci which fail to clump in the presence of 
fibrinogen. This assumption is further supported by the observation that 
localized infection in the peritoneal cavity and viscera was absent after 
the intraperitoneal injection of clumping factor-negative organisms, but 
was usually observed with the clumping factor-positive organisms regard­
less of their coagulase activity (Table 15).
Following the intraperitoneal injection of clumping factor-negative 
organisms, irrespective of their coagulase property, fewer organisms may 
be subject to initial phagocytosis in the peritoneum. A relatively high 
proportion of the organisms would then dessiminate and multiply in the 
blood and other organs and thus escape the phagocytes which are subse­
quently mobilized into the peritoneal cavity (Wilson and Miles, 1955). 
With the extensive dessimination and multiplication of the organisms com­
bined with high concentrations of toxins including delta hemolysin, the 
staphylococci would then overcome the animal defense mechanisms. The 
evidence presented here indicates that this sequence of events is more 
apt to occur and it requires relatively smaller doses when clumping fac­
tor-negative, coagulase-positive staphylococci are injected intraperiton- 
eally than when clumping factor-negative, coagulase-negative organisms 
are inoculated. The possibility that loss of clumping factor activity 
may also be associated with a change in the antigenic composition of the 
cells must also be considered as an explanation of the unusual virulence 
of these organisms.
In contrast, following the injection of a comparable dose of clump­
ing factor-positive staphylococci, a higher proportion of the organisms 
are probably subjected to initial phagocytosis in the peritoneum.
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Likewise, more efficient and localized phagocytosis of the dessiminated 
organisms may occur in the blood and other organs. Death time of the 
animal, if it occurs, would then be prolonged, unless the challenge doses 
were overwhelmingly large.
Rogers (1956a,b,c, 1959, 1960) reported that 10 to 15 minutes after 
the intravenous injection of rabbits with staphylococci, the great major­
ity of the organisms are trapped in the liver and spleen and 90 per cent 
of the organisms circulating in the blood appeared to be phagocytized.
With the intravenous inoculation of large doses, the splanchnic tissue 
no longer traps staphylococci and, as a result, a prolonged bacteremia, 
lasting for hours to several days, results. Benacerraf et (1959) 
reported that when heat killed, p-32 labelled staphylococci were injected 
intravenously into mice, rapid clearance of the blood occurred. This 
clearance followed an exponential function of time, and within 10 minutes 
most of the bacteria were phagocytized in the reticuloendothelial system, 
principally the liver and spleen.
Considering the above observations and the results of intravenous 
inoculation of mice reported here, it may be assumed that, due to their 
dispersion in the blood, clumping factor-negative staphylococci are phago­
cytized less efficiently by the circulating leukocytes. If this is the 
case a large portion of the inoculum would then be free to dessiminate 
into the various organs. Conversely, a relatively larger number of clump­
ing factor-positive staphylococci would be readily available for the cir­
culating phagocytes. This assumption is in line with the idea that intra- 
vascular clumping of bacteria is a mechanism contributing to their removal 
from the blood stream (Rogers, 1960).
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Reappearance of an overwhelming number of the coagulase-positive 
staphylococci, regardless of the clumping factor property, would then 
occur in the blood stream following their intracellular survival and 
multiplication. This event may be accompanied with marked transient 
granulocytopenia due to the active destruction of leukocytes (Gray et £l., 
1957; Rogers and Melly, 1957). Reappearance in the blood of larger num­
bers of coagulase-positive, clumping factor-positive organisms than of 
clumping factor-negative, coagulase-positive staphylococci would be 
expected if initially more of the former cells were trapped in the cir­
culating phagocytes. Subsequently, earlier death of the animals would 
occur following intravenous injection with coagulase-positive, clumping 
factor-positive organisms than with comparable doses of coagulase-posi­
tive, clumping factor-negative organisms.
Unless overwhelming doses are injected, destruction and elimina­
tion of coagulase-negative organisms appear to follow their intravenous 
injection. However, clumping factor-positive, coagulase-negative organ­
isms were more efficient in establishing infection than are the coagulase- 
negative, clumping factor-negative staphylococci.
Several investigators (Tompsett, 1954; Gccdman and Moore, 1956; 
Goodman et al., 1956; Rogers, 1959), have indicated that whereas coagulase- 
positive staphylococci survive and multiply inside phagocytes with subse­
quent destruction of the phagocytes, coagulase-negative staphylococci are 
destroyed by the same phagocytes. It would be of interest to investigate 
the interaction between phagocytes and staphylococcal clumping factor.
In the present investigations, two strains of coagulase-negative, clumping 
factor-positive survived in mice and were almost as successful in
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establishing infection as were the coagulase-positive strains. These 
.. staphylococci showed average and ID^Q values comparable to those
of the coagulase-positive strains and higher than those of the coagulase- 
negative, clumping factor-negative organisms (Tables 10 and 11). It is 
noteworthy that coagulase-negative staphylococci which possessed strong 
clumping factor activity (Hv 1 and S 35s) exhibited all of the other 
in vitro properties which are usually associated with pathogenic staphylo­
cocci.
Exceptions to these general observations were encountered. The 
Smith "mouse virulent" variant (the Sv strain of Group I) like the other 
coagulase-positive, clumping factor-negative staphylococci, was more 
virulent when injected intraperitoneally than intravenously, but it was 
also the most virulent of the 13 strains by the intravenous route. There 
is no doubt that the Sv strain possesses some factor or factors yet to be 
recognized which contribute to its unusual virulence by both routes of 
injection. It may be justifiable, however, to consider that its high 
coagulase activity, which incidentally was remarkable because it clotted 
mouse plasma (Table 9), combined with its failure to clump in fibrinogen 
may contribute to increased dessimination and resistance to phagocytosis. 
On the other hand, the coagulase-positive, clumping factor-positive V 
strain of Group I was almost equally virulent whether injected intra­
venously or intraperitoneally. It was true that it possessed strong 
coagulase activity, but its coagulase titer was not as high as that of 
the less virulent S strain of the same group. No significant difference 
was noted in the other properties of this strain.
The reported differences in the IDgg values of the staphylococci
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tested are expressed further by the time which was required for com­
parable doses of each of the staphylococci to kill the mice (Table 12).
The more virulent the strain the quicker the mice died. Likewise, the 
effect of the route of injection was noted here. Mice were killed in a 
shorter time when injected intraperitoneally with clumping factor-negative 
staphylococci, which were more virulent by this route, than when injected 
with the same dose intravenously. The opposite was true for the clumping 
factor-positive strains, which were more virulent intravenously. This 
observation is more striking when lower doses of these strains are com­
pared, since death caused by the higher doses may very well be due to the 
overwhelming numbers of organisms injected.
When injected intravenously into an experimental animal, various 
strains of staphylococci are reported to have a peculiar and predictable 
organ tropism (Elek, 1959; Rogers, 1959). Although most staphylococci 
are trapped initially in the liver and spleen following their intravenous 
inoculation, they subsequently multiply within the renal tissues (Dyke, 
1923; De Navasquez, 1950; Gorrill, 1951; Smith, 1956; Smith and Dubos, 
1956a; Gray et , 1957; Sellers and Le Maistre, 1960). In agreement 
with previous observations, the present investigation indicates the pro­
gressive multiplication and persistence of staphylococci in the kidneys 
of mice injected intravenously and, to lesser extent, following intra­
peritoneal injection.
Kidney infection resulted in progressive renal damage and the degree 
of this damage seemed to determine the course and outcome of infection.
It is of interest that different gross and microscopic pathological mani­
festations were observed in the kidney depending on the coagulase and
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dumping factor characters of the strain. The multiple, grossly visible 
abscesses formed by clumping factor-positive organisms might be explained 
on the basis of the aggregation of organisms, due to their clumping in 
plasma. In contrast, clumping factor-negative organisms might cause dif­
fuse rather than localized infection. It has been suggested that coagu­
lase-negative staphylococci readily traverse the renal capillaries of 
rabbit kidneys, whereas coagulase-positive staphylococci produce emboli 
in the smaller vessels which lead to abscess formation (Dyke, 1923;
De Navasquez, 1950).
Thompson and Dubos (1938) were able to produce osteomyelitis regu­
larly in rabbits by intravenous injection of a staphylococcal strain.
One of the 13 staphylococci tested, the coagulase-positive, clumping 
factor-positive S 33 strain, had a noticeable predilection for the skele­
tal muscles, with subsequent bone involvement, rather than for the kidney. 
The involvement of a less vital organ may have resulted in the comparably 
high LDgQ values of this strain (Table 10).
Organ selectivity by staphylococci is a puzzling phenomenon and 
much more understanding of host-parasite relationships is required before 
any explanation of its mechanisms can be attempted. Nevertheless, sus­
ceptibility of the kidney, which is a highly vascularized organ, may be 
due to the absence of fixed phagocytes such as those present in the liver 
and spleen. Renal abscesses resulted more frequently and extensively 
following the intravenous than the intraperitoneal inoculation of com­
parable doses of the organisms. Smith and Dubos (1956a) and Gorrill
(1958) suggested that kidney infection and abscess formation are initiated 
by a few mechanically trapped organisms. However, the number of organisms
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trapped appeared to depend on the size of the dose as well as on the 
nature of the staphylococci injected. As Gorrill (1958) pointed out, 
if enough organisms are present, some begin to divide and establish 
themselves before the cellular defenses of the body are alerted.
Staphylococci injected intravenously were more successful in es­
tablishing infection than those injected intraperitoneally. The ID^q 
values of 12 of the 13 staphylococcal strains tested were lower for the 
intravenous than for the intraperitoneal route of injection.
Several properties have been associated with the ability of staph­
ylococci to produce disease in man and experimental animals (Dubos,
1956; Elek, 1959). Previous speculations emphasize mainly coagulase and 
alpha hemolysin as virulence factors. Recently, North (1959), by the 
use of specific alpha antitoxin, was successful in protecting mice against 
experimental staphylococcal infection. In the present investigation, how­
ever, alpha hemolysin was produced by only 2 of the 13 strains (S 35 and 
Hv 1) and these were among the less virulent strain studied (Tables 4 and 
10), The production of delta hemolysin by 12 of the 13 strains would 
support previous suggestions as to its significance in the virulence of 
staphylococci (Jackson and Little, 1956, 1957; Johanovsky, 1957b). The 
S 33 strain, which produced beta hemolysin only and failed to hemolyze 
mouse blood, was one of the least virulent strains and it had a predilec­
tion for the skeletal muscle.
The ability of coagulase to exert its plasma coagulating activity 
in vivo is a controversial issue. Iforeover, mouse plasma is not ordinar­
ily clotted in vitro by coagulase. Nevertheless, the difference in the 
survival of coagulase-positive and coagulase-negative staphylococci in
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the host animal supports the role of coagulase as a virulence factor, as 
does the usual observation that only coagulase-positive staphylococci 
are pathogenic for experimental animals. There is also strong evidence 
for a protective role of coagulase against the bactericidal power of 
serum as well as against that of phagocytosis.
Although Smith and Dubos (1956a) could arrange strains of staphylo­
cocci in a continuous spectrum according to their ability to cause disease 
in mice, which, in turn, appeared to correlate with coagulase production, 
they disputed the idea that coagulase was a factor of pathogenesis in 
this infection. The present study suggests that coagulase-negative as 
well as coagulase-positive staphylococci are able to resist early phago­
cytosis and to establish infection in mice. However, results here indi­
cate, that, in general, coagulase-positive staphylococci were more viru­
lent and more infective for mice than coagulase-negative strains regard­
less of clumping factor activity (Tables 10 and 13; Figures 4 and 5).
The prolonged persistance of coagulase-positive organisms in in­
fected tissues may suggest a protective role for coagulase at the later 
stages of infection. Coagulase-negative staphylococci were eliminated 
from infected tissues at a much earlier stage and when they persisted for 
two weeks post-infection, they were present in relatively low numbers.
On the other hand, within each of the two coagulase-positive staphylo­
coccal groups there is some correlation between virulence and coagulase 
production (Table 10). An exception is encountered when the V and S 
strains of Group II are compared. The S strain produced coagulase to a
high titer (1:1024) and was able to clot mouse plasma vitro, but it
was less virulent intravenously and intraperitoneally than the V strain
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which exhibited a 1:256 coagulase titer, and failed to clot mouse plasma. 
The factors which allow multiplication and persistence of staphylococci 
in the host tissues are not known, and better understanding of the organ­
isms as well as of the host factors are required before any speculations 
in this area can be made.
Some support of the significance of coagulase in the pathogenicity 
of staphylococci may be obtained when the virulence and infectivity of 
parent strains are compared with those of their variants. The Hv 1 (Group 
III) and Hv 2 (Group IV) strains had lower intravenous and intraperitoneal 
LD5O and ID50 values than their parent, the H strain (Group II), from 
which they differed by loss of coagulase activity. The coagulase-negative 
S 33v (Group IV) variant was much less virulent intravenously, but less 
so when injected intraperitoneally, than its parent, the coagulase-posi­
tive S 33 strain. Also, its intravenous and intraperitoneal ID^q were 
much higher than those of the parent strain. As noted above, the coagu­
lase-negative Hv 2 and S 33v variants were more virulent for mice when 
injected intraperitoneally than intravenously although less so than their 
respective coagulase-positive strains.
Further study of a larger series of representative strains is neces­
sary before any correlation can be made regarding the possible relation­
ship between the ^  vitro properties of staphylococci and their virulence 
for mice. However, there was, in general, better correlation between the 
in vitro properties, which are often associated with virulence, and clump­
ing factor property than between these properties and coagulase produc­
tion. This observation is quite evident in the case of pigment produc­
tion and phage typability (Table 4). It is also apparent that no complete
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correlation can be made between the various properties tested and any 
single character such as coagulase production.
Although aureus does not normally possess a capsule, there are 
references in the literature to the isolation of encapsulated, mucoid 
staphylococcal strains (Elek, 1959). Lyons (1937) demonstrated a capsule 
in very young (1 to 3 hour) staphylococcal cultures, and considered the 
capsule to be responsible for the invasiveness of the organism. Price 
and Kneeland (1954) obtained an encapsulated variant, which was the same 
phage type as the parent strain, after passage of the non-capsulated 
parent strain in embryonated hen's eggs. Wiley (1959) isolated mucoid 
encapsulated variants of aureus, the cells of which exhibited capsular 
swelling reactions with specific immune serum. He also demonstrated 
passive protection with hyperimmune rabbit and rooster serum, as well as 
with human globulin, against infection of embryonated hen's eggs by an 
encapsulated strain of aureus. The same worker (Wiley, 1960) reported 
that sera of 80 per cent of a group of blood donors contained anti- 
capsular antibodies although only 4 of the 109 donors examined were 
nasal carriers of encapsulated staphylococci. The production of what 
may be a mucopolysaccharide substance by the mucoid K 93m variant of the 
K 93 strain resulted in an increase in its intraperitoneal LD^q and ID5Q 
values. It is possible that the formation of a non-protective slime 
layer would retard the dessimination of the organisms from the peritoneal 
cavity and subject the organisms to earlier phagocytosis.
There are several implications of these results. They emphasize the 
dependence of measures of virulence, such as the LD^g, on the route of 
injection. In association with the route of injection, re-evaluation of
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the significance of coagulase and clumping factor as factors of staph­
ylococci virulence seems necessary. The present investigation fails 
to confirm the assumption that rare strains of staphylococci which are 
positive for either coagulase or clumping factor, but not both of these 
properties, are of doubtful pathogenicity. Although coagulase may con­
tribute to the persistance of staphylococci in an infected animal, its 
absence in the clumping factor-positive organisms did not deprive them 
of their ability to persist vivo. However, when the staphylococci 
lacked both coagulase and clumping factor, lowered virulence and infec­
tivity resulted. On the other hand, the coagulase-positive, clumping 
factor-negative staphylococci tested were notably more virulent than any 
of the staphylococci tested when injected intraperitoneally into mice. 
Thus, it seems reasonable to suggest that both coagulase and clumping 
factor are of significance in the virulence of staphylococci. The clump­
ing factor appears to play its role in the early stages of infection, 




A soft agar medium which is efficient in the simultaneous demon­
stration of the coagulase and clumping factor activities of staphylococci 
is described. This technique reveals rare strains of staphylococci which 
are positive for one of these properties exclusively, and it facilitates 
isolation of such variants from mixed staphylococcal populations.
Thirteen strains representing typical coagulase-positive and coagu­
lase-negative staphylococci, as well as staphylococcal variants with 
unusual combinations of coagulase and clumping factor activities, were 
selected for virulence studies. The LD^Q and values of each strain
were determined by injecting challenge doses of washed cells into mice 
by the intravenous and intraperitoneal routes.
Regardless of their coagulase activity, clumping factor-negative 
strains of staphylococci were more virulent, as judged by ID50 values, 
when injected intraperitoneally than when introduced by the intravenous 
route. Conversely, staphylococci which possess the clumping factor, 
either with or without coagulase, appeared to be more virulent by the 
intravenous route. The most virulent of all strains tested by the intra­




In the experimental infections, the degree of kidney involvement 
appeared to determine whether or not the animal survived. A strain which 
showed remarkable predilection for skeletal muscles, rather than the 
usual tendency of staphylococci to localize in kidney tissues, was less 
virulent than other -strains with similar coagulase and clumping factor 
activities.
In general, ID5Q values indicate that infection was established 
more readily when the staphylococci were introduced by the intravenous 
rather than by the intraperitoneal route.
The least virulent of the staphylococci tested were the first to be 
eliminated. They disappeared from the tissues by the second to the fourth
post-infection week, whereas the more virulent staphylococci persisted in
the tissues of mice for as long as 6 to 8 weeks. The kidney was the most
common site of persisting infection.
During the course of the virulence studies, certain variations in 
the ^  vitro properties of the selected strains were observed. Noteworthy 
among these was a mucoid variant which was recovered from the infected 
mice. The cells of this variant were enveloped in a demonstrable slime 
layer if not in a discrete capsule. The mouse virulence of the mucoid 
strain was less than that of the coagulase-positive, clumping factor- 
negative parental type.
From the evidence of these studies it is not possible to assign 
staphylococcal virulence to any particular vitro property of the or­
ganisms. In general, the coagulase-positive strains were more virulent 
than the coagulase-negative strains. However, in certain instances, 
coagulase production could not explain the degree of virulence. Strains
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with the same or greater coagulase producing ability than others were 
not necessarily equal or proportionally higher in virulence.
Lack of an undefined cell surface component or activity, known 
variously as bound coagulase, clumping factor or, in terms of the soft 
agar technique, colony compacting factor, was a common property of the 
rare strains of staphylococci which have unusually high virulence for 
mice when injected by the intraperitoneal route.
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